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ABSTRACT 
This study examined the physiological and psychological stressors of hospitalized acute 
myocardial infarction (AMI) patients who abruptly ceased smoking. A cross-sectional 
survey was conducted on 57 AMI patients (29 smokers and 29 non-smokers) on day two 
following admission to the coronary care unit. Psychological stress was measured using the 
Profile of Mood States and the Insomnia Severity Index. Retrospective chart abstraction 
was conducted to examine the impact of smoking cessation on the physiological outcomes. 
MANCOVA suggested that after adjusting for age, smokers experienced significantly 
higher levels of depression, anxiety and anger as compared to the non-smokers. Student t-
tests and chi-square analyses revealed no differences in length of stay, ischemia and 
arrhythmia between the two groups. The findings support some propositions of the 
Transactional Model of Stress and Coping, and offer support for continued assessment and 
research related to the management of nicotine withdrawal following AMI. 
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The experience of acute myocardial infarction (AMI) represents a time of stress in 
terms of both emotional impact and lifestyle change (Fleury & Moore, 1999; Stewart, 
Davidson, Meade, Hirth, & Makrides, 2000). This is particularly true among hospitalized 
patients (De Jong, Moser, An, & Misock., 2005; Grace et al., 2005; Mayou et al., 2000). 
When hospitalized, AMI patients who routinely engage in smoking are unable to utilize 
tobacco as a possible means of coping. This is problematic for these individuals given 
that smoking has been reported by post-AMI patients as a means of coping with stressful 
situations (Bennett, Lowe, Mayfield, & Morgan, 1999). In addition, when smokers cease 
utilizing tobacco, they experience symptoms of withdrawal, which is also associated with 
anxiety and depression (Hughes, 1992; Gritz, Carr, & Marcus, 1991). The simultaneous 
convergence of these events may result in physiological and psychological effects that 
could be detrimental to hospitalized AMI patients. Therefore, determining the impact of 
abrupt nicotine withdrawal on this population may provide greater insight into the stress 
and coping of smoking AMI patients. Furthermore, identification of the stressors and 
coping strategies utilized by AMI patients may assist clinicians and educators to design 
and implement evidence-based interventions to assist coping during this uncertain time. 
Finally, the introduction of early interventions to minimize the effects of nicotine 
withdrawal and facilitate smoking cessation may reduce associated morbidity and 
mortality in this patient population. 
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Significance of the Problem 
In Canada, heart disease is not only the number one cause of death, but it 
represents the most significant burden on the national health care system (Health Canada, 
2007). When compared to the rest of the country, the direct and indirect costs associated 
with the treatment of cardiovascular disease in Ontario are significantly greater than all 
other Canadian provinces (Public Health Agency of Canada, 2003). Smoking represents a 
significant risk factor for ischemic heart disease. In fact, smokers are two to three times 
more likely to die from coronary heart disease (CHD) than non-smokers (American Heart 
Association, 2005). Statistics reveal that in 1998,22% of all deaths in Canada were 
related to smoking (Makomaski Illing & Kaiserman, 2004). Of these smoking-related 
deaths, ischemic heart disease was the second highest cause of death. 
The issue of CHD and smoking is of considerable concern in Windsor-Essex 
County. In this population, ischemic heart disease is the leading cause of death in men 
and women (Windsor-Essex County Health Unit, 2003). In fact, the Windsor-Essex 
County Health Unit reported that among women, the rate of coronary artery disease 
(CAD) in Windsor is 29% higher than the provincial average, with the rate among men 
being 28% higher than the provincial average. It also reported that 26% of adult males, 
24% of adult females and 33% of teens smoke on a daily basis. VanderKaay and 
Patterson (2006) suggested that individuals who smoke one pack of cigarettes per day 
have a two and a half times greater chance of developing CHD than non-smokers. 
Further, Mehta and Eagle (1998) suggested that smoking increases the risk of an initial 
cardiac event and doubles the rate of a subsequent infarction. 
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There is strong clinical evidence suggesting that smoking cessation is probably 
the single-most powerful lifestyle intervention with regard to the prevention of 
cardiovascular disease (CVD) (American Heart Association, 2005; European Society of 
Hypertension, 2003). In fact, it has been suggested that smoking cessation results in a 
50% decrease in mortality and morbidity associated with CVD (American Heart 
Association; Dalai, Evans, & Campbell, 2004; Wilson, Gibson, Willan, & Cook, 2000). 
Furthermore, quitting smoking reduces the risk of a second heart attack or sudden death 
by 20 to 50 percent among individuals who have suffered AMI (Critchley & Capewell, 
2003; Heart and Stroke Foundation, 2002). 
Due to the addictive nature of nicotine, smoking cessation remains a difficult 
process. The Centers for Disease Control and Prevention (2006) suggested that most 
individuals engage in two to three attempts, or more, before achieving success. In fact, it 
has been reported (University of Wisconsin Center for Tobacco Research and 
Intervention, 2004) that 90% of abrupt smoking cessation attempts are unsuccessful. This 
is probably due to the fact that the onset of nicotine withdrawal can occur within only a 
few hours after the last cigarette consumed, with peak symptoms occurring within a few 
days and lasting up to several weeks (Gritz et al, 1991). These symptoms often include 
anxiety, stress, irritability, depression, decreased concentration, insomnia, headache and 
tightness in the chest (Health Canada, 2005; VanderKaay & Patterson, 2006). 
Interestingly, stress has been cited as a trigger for relapse among those who are 
attempting to quit smoking (Heart and Stroke Foundation, 2001). Furthermore, studies 
have suggested that adequate resources such as education, behaviour modification and 
drug therapy are essential components of successful smoking cessation programs 
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(American Heart Association, 2005; Heart and Stroke Foundation, 2008; Mallin, 2002; 
National Cancer Institute, 2006). 
Despite knowledge of the physical and psychological stressors associated with 
smoking cessation, it is a standard practice to impose strict and abrupt smoking cessation 
restrictions upon patients who are hospitalized for the treatment of AMI. Such a practice 
is problematic given that studies have suggested a correlation between clinical symptoms 
of CAD and high levels of life stress (Ariyo et al., 2000; Spence, Barnett, Linden, 
Ramsden, & Taenzer, 1999). Furthermore, anxiety and depression among newly 
diagnosed AMI patients is common (Crowne, Runions, Ebbesen, Oldridge & Streiner, 
1996; De Jong et al., 2005) and may later predict the occurrence of adverse cardiac 
events (Carney, Freedland, Eisen, Rich, & Jaffe, 1995; Frasure-Smith, Lesperance, & 
Talajic, 1993; Grace et al., 2005). 
De Jong et al. (2005) suggested that 10 to 26 percent of hospitalized persons with 
AMI are more anxious than those who have been diagnosed with a psychological 
disorder. Moser and Dracup (1996) reported that individuals with higher states of anxiety 
after AMI have a 4.9 times higher incidence of in-hospital complications, such as 
reinfarction, acute ischemia, sustained ventricular tachycardia, ventricular fibrillation and 
in-hospital death. In addition to its impact on the physiological outcomes of AMI 
patients, psychological distress may also interfere with an individual's ability to return to 
work (Lewin, 1995) and his or her ability to engage in necessary self-care behaviours and 
lifestyle changes (Lawrence & Lawrence, 1987). In fact, smoking cessation is one 
lifestyle change is impeded by psychological distress (Brown & Mumford, 1984). That is, 
individuals who experience increased stress are less likely to succeed in quitting. 
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Although there is empirical evidence to support the relationship between 
smoking cessation and stress (Cohen & Lichtenstein, 1990; Parrot, 1992; VanderKaay & 
Patterson, 2006), little is known about: (a) the impact of abrupt smoking cessation on the 
stress levels of hospitalized AMI patients, and (b) whether stress resulting from abrupt 
smoking cessation increases the physical complications experienced by these patients. 
That is, to date, no studies have examined the psychological and physiological impact of 
abrupt smoking cessation in hospitalized AMI patients. Such research may aid nurses in 
minimizing the associated physiological and psychological stress, and in developing 
interventions to improve coping during the initial stages of the AMI experience. In 
addition, positive coping with smoking cessation during hospitalization may translate into 
long-term smoking cessation, which may lead to reduction in morbidity and mortality 
rates. 
Purpose of the Study 
The general purpose of this study is to develop a greater understanding of the 
physiological and psychological stressors of hospitalized AMI patients who abruptly 
cease smoking. Specifically, the proposed study will (a) compare the psychological 
indicators of stress between smoking and non-smoking hospitalized AMI patients (b) 
compare the outcomes of smoking and non-smoking patients with respect to differences 
in length of stay, cardiac arrhythmia, re-infarction and arrhythmia; and (c) examine the 




The Transactional Model of Stress and Coping 
The Transactional Model of Stress and Coping is a theoretical framework for 
evaluating how individuals cope with stressful events (Lazarus & Folkman, 1984). 
According to this framework, stress and coping can impact the psychological well-being, 
health behaviours, and the physical health of individuals. The theory further asserts that 
appraisal processes impact emotional responses, and that coping strategies are utilized by 
individuals in order to reduce negative emotions and maintain positive emotional 
responses. Key assumptions of this framework will be examined in order to better 
understand how coping efforts impact adaptation to stress. A modified version of the 
model is presented in Figure 1 on the subsequent page. Only the concepts which support 
the relationships being examined are included in the adapted model. 
The Appraisal Process 
When a person is faced with a stressor, the individual engages in both primary 
appraisal and secondary appraisal (Lazarus & Folkman, 1984). Primary appraisal refers 
to the individual's perception of an event as being potentially threatening to personal 
well-being. When an individual suffers an AMI, he or she may or may not perceive the 
situation to be threatening. This assessment is dependent upon a number of factors, 
including the severity of the AMI symptoms and use of defense mechanisms, such as 
denial. The individual's ability to assess options for coping, or control the outcomes or 
emotions associated with the stressor is referred to as secondary appraisal. Thus, 
secondary appraisal may include the ability of an AMI patient to assess available support 
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Mediating Processes Outcomes 
Primary Appraisal 
• Perceived susceptibility 
• Perceived severity 
• Motivational relevance 
• Causal focus 
— • 
Coping Efforts 
• Problem management 
• Emotional regulation 
Adaptation 
• Emotional well-being 
• Functional status 
• Health behaviors 
Stressor 
Secondary Appraisal 
• Perceived control over outcomes 
• Perceived control over emotions 
• Perceived elf-efficacy to change situation 
Figure 1. Transactional Model of Stress and Coping, modified (Lazarus & Folkman, 1984) 
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systems and verbalize the emotions concerning the impact of the event on work, family 
and/or lifestyle. In the case of a smoker with AMI, the individual generally finds that 
one of his or her usual coping strategies, smoking, is not an option in the hospital 
environment. 
The primary and secondary appraisal processes combine to determine the 
emotional response of the individual. For example, stress in the AMI patient is mediated 
by the individual's lack of ability to change the situation, and his/her perceived ability to 
manage one's emotions or effectively cope with the situation. Thus, greater emotional 
distress is expected in a patient who experiences a negative perception of coping options 
and perceives AMI to be a threat to well-being. 
Coping Efforts 
According to Lazarus and Folkman (1984), the outcomes of the coping process 
are influenced by coping efforts, which include both problem-focused strategies and 
emotion-focused strategies. In order to alter or change a situation to one that is more 
consistent with personal desires, an individual engages in cognitive efforts that are 
problem-focused. Also known as problem management strategies, these problem-focused 
efforts may include active problem solving and information seeking. Conversely, 
emotion-focused efforts involve processes to minimize the stressful nature of the 
situation. These efforts may involve redirecting attention away from the distressing 
elements of the situation, or by re-interpreting the situation in a novel or more favourable 
manner. According to Lazarus and Folkman, the problem-focused strategies which are 
characterized as being positive, active and expressive, result in significantly higher levels 
of functioning and psychological well-being. These authors further assert that emotion-
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focused coping strategies are used most often when the stressor is unchangeable. 
Emotion-focused coping strategies may include efforts such as avoidance, denial, social 
support, and venting of feelings. 
Outcomes 
An individual's adaptation to a stressor is measured in terms of coping outcomes 
(Lazarus & Folkman, 1984). These outcomes are manifested following initial appraisal of 
the situation (primary appraisal) and an assessment of available resources (secondary 
appraisal). Both of these processes are influenced by emotion-focused and problem-
focused coping efforts. Coping outcomes may be categorized as emotional well-being, 
functional status and health behaviours. Lazarus and Folkman define functional status as 
including concepts such as health status, physical limitations and disease progression. 
For the purpose of this study, the impact of loss of usual coping strategies (i.e. 
smoking) on the stress and adaptation of the individual will be examined. An illustrative 
representation of the relationships among the concepts of interest is presented in Figure 2 
on the subsequent page. Given the fact that individuals have reported smoking as a means 
of coping or diverting attention from stressful situations (Bennett et al., 1999), this study 
proposes that smoking can be considered an emotion-focused coping effort. Among 
hospitalized AMI patients, smoking is not an available emotion-focused strategy, and 
AMI is not a changeable stressor. Furthermore, when abrupt smoking cessation is 
imposed upon an AMI patient, the symptoms of nicotine withdrawal represent additional 
stressors. A patient's adaptation to the stress associated with the AMI and abrupt smoking 
withdrawal is represented by coping outcomes. These outcomes include indicators of 












Figure 2. Study Application of the Transactional Model of Stress and Coping 
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functional status may be manifested through physical outcomes, such as length of stay, 
angina, arrhythmia or re-infarction. Thus, when applied to this patient population, the 
Transactional Model of Stress and Coping (Lazarus & Folkman, 1984) suggests that 
smokers will experience greater distress than those who do not smoke. That is because, 
unlike non-smokers, smokers are unable to utilize smoking as an emotion-focused coping 
strategy. The model further predicts that there will be a difference in the measures of 
functional status between smokers and non-smokers. In addition, the framework suggests 
that the coping outcomes may interact with one another. That is, there is a relationship 
between emotional well-being and functional status. Therefore, when applied to this 
population, this study posits that there is a reciprocal relationship between measures of 
mood and insomnia and functional status of the AMI patient, as measured by length of 
stay, re-infarction, cardiac ischemia and arrhythmia. The relationship between these 
concepts is depicted in Figure 2. 
Research Questions 
1. Is there a difference in the psychological well-being of smoking and non-
smoking AMI patients as measured by insomnia, tension/anxiety, 
depression/dejection and anger/hostility, fatigue/inertia? 
2. Is there a difference in the functional outcomes of smoking and non-smoking 
AMI patients as measured by length of stay, arrhythmia, re-infarction and cardiac 
ischemia? 
3. Is there a correlation between the functional status and psychological well-being 
of patients following AMI? 
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Significance for Nursing 
The issue of stress and coping among smokers has not been extensively studied in 
the hospitalized AMI population. In fact, no known studies exist that have sought to 
understand both the physiological and psychological outcomes of smoking cessation in 
this population. Therefore, new knowledge may provide significant implications for both 
research and nursing practice. Recognition of the causes and deleterious effects of 
psychological distress in AMI patients is essential for the achievement of positive 
psychological and physiological outcomes. As compared to other health care providers, 
nurses are in a particularly unique position to assess and implement strategies to decrease 
stress and enhance positive coping patterns among AMI patients. Given that anxiety, 
depression and coping patterns are amenable to nursing intervention (Conn, Taylor, & 
Wiman, 1991), this study may suggest salient interventions for enhancing both the 
physiological and psychological outcomes of hospitalized AMI patients. Such 
interventions are anticipated to bring about subsequent reduction in morbidity and 
mortality, and improvement in post-AMI quality of life. Furthermore, dissemination of 
the knowledge of the potential negative psychological and physiological outcomes of 
abrupt nicotine withdrawal during hospitalization following AMI may serve as an 
impetus for individuals at risk for AMI to engage in smoking cessation prior to the 
occurrence of negative cardiac events. Consequently, this behaviour change would reflect 
an important means of promoting primary prevention for cardiovascular disease in at risk 
populations. 
The findings of this study can be utilized to conduct future research studies in this 
population. Intervention studies utilizing validated smoking cessation strategies may 
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demonstrate improved coping and successful reductions in both stress and cardiac 
outcomes in hospitalized AMI patients. Furthermore, successful coping with smoking 
cessation during hospitalization may translate into long-term smoking cessation, which 
may lead to subsequent reduction in associated morbidity and mortality rates. 
14 
CHAPTER II 
REVIEW OF THE LITERATURE 
Search Strategy 
Research findings presented in this literature review were obtained through a 
systematic review using five electronic databases: Proquest, Medline, Pubmed, the 
Cochrane Database of Systematic Reviews and the Cumulative Index of Nursing and 
Allied Health Literature (CINAHL). In addition, published theses and dissertations were 
searched. Keywords used in the search process were stress, coping, anxiety, depression, 
smoking and hospitalization. These keywords systematically searched in varying 
combinations with the keywords: acute myocardial infarction or heart attack. The 
keywords were present in the title, abstract, or the text of the article. This approach 
yielded 15 published peer reviewed articles and one doctoral dissertation. Bibliographies 
of the research studies obtained from the search process were further scanned for 
potentially relevant articles. This resulted in 8 articles. An e-mail address of one author 
obtained via an internet search was utilized to obtain one additional article. Thus, the 
search process yielded a total of 24 articles and one doctoral dissertation. 
The Review 
The Physiological and Psychological Impact of Nicotine Withdrawal 
A number of studies have suggested that cessation of nicotine consumption 
impacts the smoker and produces withdrawal symptoms. In cardiac patients, smoking 
cessation is associated with improved cardiac outcomes (American Heart Association, 
2005; Dalai et al , 2004; Wilson et al., 2000). However, abrupt smoking cessation during 
the initial hospitalization phase of AMI could potentially lead to physical and 
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psychological stress that could impede these outcomes. The following section 
summarizes findings specific to this issue. 
In a prospective study of 554 unaided quitters, tobacco withdrawal was assessed 
in order to better understand the nature of withdrawal (Gritz et al., 1991). Data were 
collected at baseline, 1 week, 1 month, 3 months, 6 months and 12 months. Participants 
completed a questionnaire that solicited information concerning the degree of nicotine 
dependence and nature and severity of withdrawal symptoms. The vast majority of 
abstainers reported experiencing one or more withdrawal symptoms at day 1 (87.0%), 
day 2 (90.3%) and week 1 (97.5%). Specifically, symptoms of anxiety (44%, 49%, 42%, 
respectively for days 1,2 and at week 1) and restlessness (47%, 55%, 47%, respectively 
for days 1,2 and week 1) were reported by smokers who remained abstinent. Repeated 
measures analyses revealed that both the number of symptoms (F = 5.58, p < .01) and the 
severity of symptoms (F = 22.94, p < .01) peaked on day 2. 
Hughes (1992) conducted a longitudinal analysis of self-reported and observer-
rated signs and symptoms of nicotine withdrawal where 178 respondents who abstained 
from smoking at two, seven, 14 and 30 day follow-ups were compared to control groups 
of 56 long-term smokers, 67 current smokers and 61 individuals with no smoking history. 
Subjects completed self-report questionnaires that solicited information regarding the 
symptoms and behaviours associated with nicotine withdrawal. Observers were recruited 
to periodically rate the subject on similar indicators. Scores for anxiety, hunger, 
irritability, decreased heart rate, depression, difficulty concentrating and restlessness were 
greater at day 30 than pre-cessation among subjects who remained abstinent. Post hoc 
tests confirmed that at day two post-cessation, anxiety, difficulty concentrating, 
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irritability, restlessness, decreased heart rate and hunger differed significantly from 
baseline. At day seven post-cessation, increase in cigarette craving was associated with 
an increase in mood symptoms (r = .34) and depression (r =.50), but nop values were 
provided. Furthermore, increases in depression were correlated with increases in 
irritability (r = .41) and anxiety (r = .45). 
VanderKaay and Patterson (2006) assessed the effects of nicotine and nicotine 
withdrawal on blood pressure and cardiac function during psychological stress. They 
subjected 46 smokers to stressors (i.e., an arithmetic task and cold), then tested their 
cardiovascular reactivity. Each participant was tested twice, once while wearing a 21 mg 
nicotine patch, and once while wearing a placebo patch. When subjected to the arithmetic 
task during nicotine withdrawal, participants demonstrated greater heart rate reactivity (t 
= 2.18, p < .04), increased systolic blood pressure (t = 2.19, p < .04), increases in anxiety 
(t = 2.30,p < .03) and anger (t = 2.38,/? < .03). Similarly, exposure to cold, while 
experiencing nicotine withdrawal, resulted in greater heart rate variability (t = 4.77, p < 
.0001) and increased diastolic blood pressure (t = 3.77,/? < .01). 
Tsuda, Steptoe, West, Fieldman and Kirschbaum (1996) examined the impact of 
smoking and temporary withdrawal on the mood and behavioural performance of 49 
individuals who were assigned to three groups: non-smokers (« = 16), regular smokers 
randomized to overnight abstinence (n = 14) and regular smokers who smoked 30 
minutes prior to testing (n = 19). Participants were administered a computerized problem-
solving task based on a series of progressively more difficult matrices. Analysis of 
variance (ANOVA) revealed that the three groups differed in terms of the percentage of 
problems they correctly solved (F= 3.13, p = .05), such that abstainers averaged 91.7%, 
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while non-smokers averaged 94.3% and recent smokers averaged 96.1%. The authors 
reported impaired behavioral performance and symptoms of nicotine craving among the 
abstinent group (p < .01). Furthermore, during the three points of data collection, 
measures of tension and anger were lower in non-smokers than either of the two smoker 
groups (p < .01). 
In a retrospective study, Rea et al. (2002) examined the association between 
smoking status and risk for recurrent coronary events in patients discharged from hospital 
following AMI. A sample of 2619 subjects who survived an initial AMI was recruited 
from a health maintenance organization in the United States. Following assessment of 
smoking status, participants were classified as non-smokers (persons with no smoking 
history), former smokers (persons who had quit prior to the AMI), quitters (persons who 
were smoking at the time of the cardiac event and quit after the infarction) and active 
smokers (persons who smoked at the time of the cardiac event and continued smoking 
following the AMI). The endpoint of interest was recurrent AMI or coronary death. 
Statistical analysis revealed that those who quit smoking after the event, but were 
smoking at the time of the AMI, had a higher hazard ratio than non-smokers (RR = 1.43, 
95% CI= 1.07-1.93) and those who continued to smoke (RR= 1.51,95%CI= 1.10-2.07). 
These findings are highly significant to the second research question, which examined 
how smoking status impacts patient outcomes. It may follow that the stress imposed by 
abrupt nicotine withdrawal increases the risk for recurrent coronary events, such as re-
infarction and cardiac death following AMI. 
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The Relationship between Stress and AMI 
A number of investigators suggested that AMI patients perceived stress to be a 
significant cause of AMI (Clark, 2003; Condon & McCarthy, 2006; Fukuoka et al., 2004; 
King, 2002; McKibbin & Wilson, 2001). Among smokers, this is problematic given that 
the stress, which is perceived to have contributed to the AMI, is compounded by the 
additional stress of abrupt nicotine withdrawal. The following text discusses research 
findings related to the physiological and psychological impact of stress following AMI 
on: (a) cardiac function and outcomes, such as acute ischemia, re-infarction, arrhythmia 
and death (b) psychological distress and coping; and (c) the subsequent ability to 
implement self-care activities. 
The Physiological and Psychological Impact of Stress 
A review of the literature provides evidence that stress following AMI impacts 
cardiac function and outcomes (i.e., length of stay in CCU, ischemia, re-infarction), 
psychological distress and coping and the ability to implement self-care activities, 
including smoking cessation. The results of these studies are summarized in the following 
text. 
Cardiac function and outcomes. Bacon et al. (2006) investigated the effects of 
mental stress on blood pressure, heart rate and cardiac output on a sample of 72 cardiac 
patients and found that stress produced significant increases in systolic blood pressure, 
diastolic blood pressure, heart rate and cardiac output (F = 55.75, F = 21.37, F = 104.37, 
F ~ 54.96, respectively, all/? < .001). The validity and reliability of this study may be 
questioned given the high refusal rate (59%) among those invited to participate. 
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Moser and Dracup (1996) conducted a prospective study to examine the 
association between early onset anxiety among AMI patients and subsequent in-hospital 
complications. The study involved multiple cardiovascular centres who were involved in 
the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded 
Coronary Arteries (GUSTO) trial. In total, 86 confirmed AMI patients were recruited. 
The Brief Symptom Inventory (Derogatis, 1975) was utilized to measure the 
psychological distress of the participants. The outcome of interest was the occurrence of 
cardiac complications including acute ischemia, re-infarction, sustained ventricular 
tachycardia, ventricular fibrillation or in-hospital death. Complications were observed in 
19.6% of patients who reported increased anxiety levels as compared to 6% of 
individuals who reported lower levels of anxiety (p = .001). When patients with higher 
anxiety were compared to those with lower anxiety, chi square analysis suggested that 
ischemia (11% vs 3%,p = .02), re-infarction (4.7% vs 0.0%,p = .04) and ventricular 
fibrillation (7.8% vs \.5%,p = .03) were significantly higher among patients with high 
anxiety. Multiple logistic regression suggested that anxiety remained a significant 
predictor of cardiac complications during hospitalization (OR = 4.9,95% CI = 2.1-12.2,/? 
= .003). 
In a 6 year cohort study, Ariyo et al. (2000) examined the association of 
depression with coronary heart disease and all-cause mortality in older American adults 
(mean age = 72 years). Measures of depression were gathered at baseline and annually 
from a sample of 4493 subjects for 6 years or until the incidence of a cardiac-related 
event or death. The findings suggested that every five point increase in mean depression 
score was associated with a 15% increased risk of developing CHD in both men and 
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women (p = .006). The hazard ratio for mortality was 1.16 (p = .006). Multivariate 
analysis further revealed that individuals with higher baseline depression scores had a 
60% higher risk for mortality (p = .012) compared to those with the lowest mean baseline 
depression scores. After controlling for confounding variables, baseline depression was 
also a significant predictor of CHD (hazard ratio =\A,p = .032) and death (hazard ratio 
= 1.6,/? = 0.012). 
Grace et al. (2005) conducted a longitudinal observational study to examine the 
relationship between depression during hospitalization for a cardiac event and subsequent 
all-cause mortality in a sample of 910 patients who were hospitalized with an acute 
coronary syndrome. Of this initial cohort, 856 were matched to the Canadian Institute of 
Health Information Discharge Abstract Database. Following this process, 750 subjects 
were determined to have a valid history of depression responses. Two hundred thirty-five 
respondents (31.3%) reported elevated depression scores during hospitalization. An 
additional 105 participants reported symptoms of depression (14.0%). The findings 
further revealed that 115 participants (15.3%) died within 5 years of hospitalization. After 
adjusting for confounders, the hazards ratios suggested that depressive symptomatology 
during hospitalization for acute coronary syndromes significantly (all/? < .001) predicted 
mortality at 2 years (1.90), 3 years (1.61), 4 years (1.76), and 5 years (1.53). 
Frasure-Smith et al. (1993) conducted a prospective study to examine the 
association between major depression in patients hospitalized following AMI and cardiac 
mortality in the first 6 months following discharge. The authors recruited 222 subjects 
from a Quebec cardiac care facility over an 11 month period. The sample was 78% male. 
In addition to demographic data and smoking status, information regarding depression 
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was gathered using a modified version of the National Institute of Mental Health 
Diagnostic Interview Schedule (DIS). The unadjusted results showed that in the six 
month period following discharge, 12 patients died of cardiac causes and that depression 
was as a significant predictor of mortality (RR = 5.1 A,95% CI = 4.6-6.87,/? = .0006). After 
controlling for confounding variables such as left ventricular dysfunction and previous 
AMI, the aforementioned association remained significant (adjusted hazard ratio = 4.29, 
95% C/= 3.14-5.44,/? = .013). 
Subsequent to the above study, Frasure-Smith, Lesperance, Juneau, Talajic and 
Bourassa (1999) examined the issue of gender differences and the impact of depression 
on one-year mortality following hospitalization for AMI. The researchers performed 
secondary analysis on data gathered from previous studies that measured depression 
symptoms during hospitalization using the Beck Depression Inventory (BDI) (Beck, 
Ward, Mendelson, Mock, & Erbaugh, 1961). Data from 896 subjects suggested that 
47.0% of women (p < .001) and 25.6% of men (p < .001) had BDI scores > 10, 
indicating symptoms of mild to moderate depression (women's mean = 11.3 + 9.3 and 
men's mean = 7.1 + 7.1). Furthermore, 8.3% of depressed women and 7.0% of depressed 
men died of cardiac causes (compared to 2.7% and 2.4% of non-depressed women and 
men, respectively). Increased BDI scores significantly predicted cardiac mortality in both 
women (OR = 3.29, 95% CI= 1.02-10.59) and men (OR = 3.05, 95% CI= 1.29-7.17). After 
controlling for other predictive factors, depression remained an independent predictor of 
cardiac mortality (OR = 3.66,95% CI = 1.68-7.99). 
Psychological distress and coping. Mayou et al. (2000) examined the association 
of anxiety and depression following AMI with the incidence of subsequent psychological 
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distress on a sample of 344 subjects who completed self-report questionnaires during 
hospitalization, and at three and 12 month intervals. Of this sample, 73% were male. The 
results suggested that more hospitalized distressed subjects were smokers (55% vs. 29%, 
p < .001). The authors also reported an association between distress during 
hospitalization and a longer hospital stay, although no supporting data analysis results 
were provided. Patients who reported higher rates of anxiety and depression during 
hospitalization continued to report higher mean scores of distress at three months and at 
one year, as compared to those who were not distressed during hospitalization (p < .05). 
Patients who experienced psychological distress during hospitalization had higher anxiety 
and depression scores at baseline, three months and one year (means = 14,10, and 10 
respectively) compared to those who were not distressed (means = 6 for all time frames). 
Lowe, Norman, and Bennett (2000) conducted a longitudinal study to examine the 
relationships among coping, emotions and perceived health among initial AMI patients in 
the first six months following the cardiac event. Use of coping strategies, emotion 
outcomes and perceived health were measured using the COPE instrument (Carver, 
Scheier, & Weintraub, 1989), the Global Mood Scale (Denollet, 1993), the short form of 
the Spielberger Stait-Trait Anxiety Inventory (Spielberger, Gorsuch, Lushene, Vagg, & 
Jacobs, 1983) and the Health Complaints Scale (Denollet, 1994) respectively. During 
hospitalization, anxiety was positively correlated with avoidant-focused coping (r = .22,p 
< .05) and negatively correlated with acceptance-focused coping (r = -.22, p < .05). 
Multiple regression confirmed these findings. The coping factors explained 16% of the 
variance in anxiety (F = 6.18, p < .001). 
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In a cross-sectional study, Chalfont and Bennett (1999) explored the relationship 
between hardiness and mood following AMI. Three to 12 months following hospital 
discharge, 59 subjects (all men) completed surveys with measures related to anxiety, 
depression and hardiness. The Hospital Anxiety and Depression Scale (Zigmond & 
Snaith, 1983) measured anxiety and depression, while the Personal Views Survey (Maddi 
& Khoshaba, 1994) was utilized as a measure of hardiness. The data suggested that 
higher depression and anxiety scores were significantly associated with lower perceived 
feelings of control (r = -.036, p < .01; r = -.49, p < .00, respectively). 
Among post-myocardial infarction patients in the United Kingdom, measures of 
mood were predicted by coping strategies; cigarette smoking was cited as a coping 
strategy to reduce stress (Bennett et al., 1999). Thirty-seven participants described 
behaviours prior to hospitalization, during hospitalization and three months following 
discharge. During hospitalization, high levels of anxiety were correlated with the 
following coping strategies: distraction (r = 0.290, p< 0.05), not seeking social support (r 
= 0.289,/? < 0.05) and disengagement (r - 0.326,p < 0.01). Depression scores in hospital 
were correlated with the emotion-focused strategies of denial (r = 0.492,/? < 0.01), 
venting of emotions (r = 0.348,/? < 0.05) and disengagement (r = 0.456,/? < 0.01). Three 
months following AMI, smoking was negatively correlated with seeking social support (r 
= -0.332,/? < 0.05). Hierarchical regression revealed that this last association remained 
after controlling for confounding variables (R2 = 0.319, p = -0.565, t = -2.742,p < 0.05). 
Ability to engage in self-care behaviours. Rose, Conn, and Rodeman (1994) 
examined the relationship between anxiety during hospitalization for AMI and self-care 
activities, including smoking cessation. Three months after hospitalization, 62 male AMI 
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patients (N= 39) completed the State-Trait Anxiety Inventory Test (Spielberger et al., 
1983) and the Health Behavior Scale (Miller, Wikoff, Garrett, McMahon, & Smith, 
1990). The results suggested that individuals who had a higher state of anxiety during the 
hospitalization period were more likely to report continued smoking behaviours three 
months after their AMI (r = -.40, p = .01). 
Conn et al. (1991) examined the relationship between anxiety, depression, quality 
of life, and performance of suggested self-care behaviours among 94 older AMI 
survivors. Following multiple regression analysis, depression predicted quality of life (ft 
= -.70, p = .001), and depression was associated with engagement in smoking {fi = -.54, p 
= .03). 
Stewart et al. (2000) provided a qualitative description of the stressors, coping 
strategies and social support experienced by AMI survivors (n = 14) and their spouses (n 
= 14). The data suggested that stressors included both the emotional impact of the event 
and lifestyle changes associated with the event. Emotional responses included fear, 
frustration, irritability, depression and feelings of being overwhelmed. Smoking, as a 
lifestyle change, was a stressor because it was often externally imposed upon the patient 
and was a source of conflict for AMI survivors and their spouses. Patients used emotion-
focused, problem-focused and relationship-focused strategies to cope with the AMI 
experience. Examples of these strategies included denial, informational support and 
active engagement through mutual problem solving, respectively. 
Shiffman (1982) conducted a cross-sectional study of ex-smokers who were 
experiencing a crisis related to relapse in smoking. They examined the coping process in 
avoiding relapse and the factors that influenced relapse episodes among ex-smokers. 
25 
Responses related to a series of open-ended questions revealed that 52% of relapses were 
precipitated by negative affect (i.e., anxiety, frustration and depression) or stress. 
Negative affect was perceived by depressed respondents as the precipitating source of the 
crisis (x2= 4.40, p<. 05). 
Smoking Status and Stress 
Utilizing a cross-sectional, descriptive design, Kuhn (1996) examined three 
domains of psychosocial functioning that distinguished between smokers, ex-smokers 
and non-smokers in hospitalized AMI patients. These domains were: (a) perceived and 
objective indices of health behaviour, (b) personality and psychopathology; and (c) social 
adjustment. This represents the only known study which has examined the direct 
relationship between smoking status and the psychological stress. A convenience sample 
of 40 patients with a confirmed diagnosis of AMI was recruited from the Ottawa General 
Hospital. Patients were classified according to smoking status. Depression was measured 
using the Brief Symptom Inventory (Derogatis, 1975). Following a one-way repeated 
measures ANCOVA, non-smokers were found to have higher depressive 
symptomatology scores than ex-smokers and smokers (F = 3.84,/? < .05). 
This study's findings must be interpreted with caution due to two statistical 
limitations. First, sample size (N= 40) might have compromised the statistical power of 
the study. Second, ANCOVA is not able to detect differences between groups on multiple 
dimensions. Furthermore, this study was limited by data collection procedures that 
occurred over an extended period from hospitalization to post-discharge, in which case, 
control over smoking status was not maintained. Finally, time of data collection was not 
26 
consistent with peak withdrawal, which occurs in the first two days following smoking 
cessation (Gritz et al., 1991; Hughes, 1992). 
Summary of the Literature Review 
Although very little is known about the relationship between the impact of 
smoking cessation on the stress and physical outcomes of AMI patients, the critical 
appraisal of the literature provides persuasive support for this study. It has been reported 
that AMI is a significant cause of stress (Fleury & Moore, 1999; Stewart et al., 2000) and 
that stress is an untoward condition in individuals with coronary heart disease (Moser & 
Dracup, 1996). Several authors reported stress as a perceived cause of AMI (Clark, 2003; 
Condon & McCarthy, 2006; Fukuoka et al. 2004; King, 2002; McKibbin & Wilson, 
2001). This is problematic given that abrupt smoking withdrawal represents additional 
psychological distress, including anxiety, depression and insomnia (Gritz et al., 1991; 
Hughes, 1992; Tsuda et al., 1996; VanderKaay & Patterson, 2006). Therefore, smokers 
may experience increased stress, thus further magnifying the actual and perceived stress 
response to the AMI. This relationship is concerning given that six quantitative studies 
reported that mood disturbances, such as anxiety and depression were associated with 
poorer physiological outcomes (Ariyo et al., 2000; Bacon et al., 2006; Grace at al., 2005; 
Frasure-Smith et al, 1993; Frasure-Smith et al, 1999; Moser & Dracup). Specifically, 
mood disturbance was associated with in-hospital complications in one study (Moser & 
Dracup) and in mortality in five studies (Ariyo et al.; Frasure-Smith et al., 1993; Frasure-
Smith etal., 1999). 
It is not known if the psychological indicators of stress differ between non-
smokers and those who are forced to quit smoking during the early phase of recovery 
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following AMI. More specifically, it is not clear if the stress of smoking withdrawal has 
an additive effect on the stress of AMI, thus leading to higher stress levels among 
smokers as compared to non-smokers. The aforementioned literature review revealed 
only one study that examined the relationship between smoking status and depression 
during hospitalization for AMI (Kuhn, 1996). Although this study suggested that smokers 
had lower depression scores than non-smokers, as previously reported, this study was 
limited by several factors including: (a) sample size, (b) statistical procedures; and (c) 
data collection procedures. 
The direct impact of abrupt smoking withdrawal on the physical outcomes 
following AMI is not known. Although the literature suggests an indirect relationship 
between stress and physical outcomes following AMI (Ariyo et al., 2000; Bacon et al., 
2006; Grace at al, 2005; Frasure-Smith et al., 1993; Frasure-Smith et al, 1999; Moser & 
Dracup, 1996), a direct relationship has not been empirically measured. One study 
reported a relationship between psychological distress during hospitalization and a longer 
hospital stay, although no supporting data analysis results were provided (Mayou et al., 
2000). 
The literature concerning psychological coping and AMI is vast, as is the 
relationship between smoking and psychological distress. However, there are no studies 
that have thoroughly examined the relationship between both of these issues. In addition, 
much of the literature related to stress and AMI to date has been conducted in male 
populations (Bacon et al., 2005; Chalfont & Bennett, 1999; Condon & McCarthy, 2005; 
Grace et al, 2005; Frasure-Smith et al., 1993; Fukuoka et al., 2004; Lowe et al., 2000; 
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Mayou et al., 2000; Rose et al., 1994). As a result, the generalizability of the findings of 
these studies may be limited. 
Furthermore, several authors reported that psychological distress during 
hospitalization was associated with subsequent maladaptive coping and negative mood 
states (Bennett et al., 1999; Chalfont & Bennett, 1999; Lowe et al, 2000; Mayou et al., 
2000). An additional two studies reported that symptoms of psychological stress were 
associated with continued smoking behaviours (Conn et al., 1991; Rose et al., 1994). 
These findings suggest that stress may impact successful cardiac rehabilitation and post-
AMI quality of life. Hence, this study provides a novel approach to a significant health 
issue, which may suggest potential implications for nursing research and practice in both 




This chapter discusses the research design, setting and sample, conceptual and 
operational definitions, inclusion criteria and procedures for protection of human 
subjects. 
Research Design 
This study employed a descriptive, cross-sectional design. The psychological 
impact of smoking cessation among AMI patients was measured via self-report 
questionnaire. Survey packages were completed by patients in the Coronary Care Unit 
(CCU) on day two following admission to the hospital with a diagnosis of AMI. In order 
to examine the impact of abrupt smoking cessation on the functional outcomes of the 
study participants, retrospective chart reviews of participant health records were 
conducted following discharge of each subject from the hospital. The research questions 
and hypotheses were tested via univariate and multivariate analyses, specifically t-tests, 
Chi-square and multivariate analysis of covariance. 
Setting and Sample 
Setting 
Study participants were recruited from two local hospitals: (a) Hotel Dieu-Grace 
Hospital in Windsor, Ontario, and (b) Windsor Regional Hospital in Windsor, Ontario. 
Given that only 14 cases were enrolled after four months, ethics approval was sought to 
add a third site to the study. Approval was granted, and data collection subsequently 
began at Chatham-Kent Health Alliance in Chatham, Ontario. The CCU's at each of the 
two Windsor hospitals were nine-bed units, thus providing a total of 18 beds which were 
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available for patient recruitment. The CCU at Chatham-Kent Health Alliance was a 10 
bed unit. Hence, a total of 28 beds were available for recruitment of study participants. 
The CCU at Hotel Dieu Grace Hospital consisted primarily of private rooms, therefore 
providing sufficient privacy and confidentiality for recruitment. A combination of private 
and semi-private accommodations comprised the design of the CCU's at Windsor 
Regional Hospital and Chatham-Kent Health Alliance. Given that participants were not 
asked to verbalize their responses, the presence of curtains was considered sufficient to 
maintain the privacy and confidentiality of responses. 
Sample 
A non-probability convenience sample was utilized to obtain subjects from the 
three research sites. Inclusion criteria was as follows: (a) a clinical diagnosis of AMI 
documented by elevated cardiac markers in the hospital record; (b) 18 years or older; (c) 
clinically stable; and (d) able to read and understand English. Patients were excluded 
from the study if they: (a) had unstable vital signs; (b) were mechanically ventilated; (c) 
required vasoactive medications other than nitroglycerin; (d) had a history of psychiatric 
diagnosis (anxiety disorder, depression or other psychiatric illness); and/or (d) engaged in 
smoking between admission and data collection, or were involved in a smoking cessation 
program prior to admission. 
Given that the findings of this research study are reported as a pilot study, 60 
participants, males and females, were recruited over a period of 9 months. Three cases, 
with incomplete data representing greater than 20% of the survey, were not included in 
data analysis. In total, 57 cases were entered into the data analysis, 29 of whom were 
actively smoking prior to hospitalization. 
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Variable Definitions 
AMI and Smoking Status 
AMI is defined by a blockage in a heart artery, which results in necrosis of the 
heart muscle (Glanze, Anderson, & Anderson, 1992). Diagnosis of AMI was confirmed 
based upon documentation of elevated cardiac markers in the patient's medical record. 
Given that the physiological and psychological symptoms of smoking withdrawal reach 
precessation levels by 30 days postcessation (Hughes, 1992), a current smoker was 
defined as an individual who reported using at least one nicotine product (cigarette, cigar, 
pipe or chewing tobacco) per day at the time of hospital admission or within one month 
prior to admission. A non-smoker was defined as an individual who had never smoked, 
never used a nicotine product, or who had quit at least one month prior to hospital 
admission. Smoking status was determined via self-report. 
Psychological Indicators of Stress 
Stress is defined as an individual's cognitive interpretation of potentially stressful 
events (Lazarus & Folkman, 1984). It involves a relationship between the demands of the 
environment and the ability to cope with these demands. Anxiety and depression are 
manifestations of stress. Anxiety is defined as a multidimensional somatic, experiential, 
and interpersonal phenomenon and may be manifested as a feeling of worry, upset, 
uncertainty, uneasiness, apprehension, or dread (Glanze et al., 1992). It is manifested by 
psychomotor manifestations of heightened musculoskeletal tension which may not be 
overtly observable (McNair, Lorr, & Droppleman, 1992). Depression is conceptually 
defined as sadness, guilt, emotional isolation, futility and feelings of personal 
worthlessness (McNair et al.). Furthermore, McNair et al. consider anger and fatigue to 
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represent symptoms of mood disturbance. Glanze et al. define anger as "a feeling of 
displeasure, rage, upset, or hostility" (p. 42) and fatigue as "a state of exhaustion or a loss 
of strength or endurance" (p. 312). 
In this study, four subscales of the Profile of Mood States Brief Version (POMS, 
McNair et al., 1992) were considered to reflect negative mood dimensions, which may be 
associated with symptoms of nicotine withdrawal. These measures of mood were: (a) 
tension/anxiety; (b) depression/dejection; (c) anger/hostility; and (d) fatigue/inertia. In the 
analysis, these dimensions were considered individual measures of mood. The POMS 
(Appendix A) has been used with many patient populations to assess transient, distinct 
mood states, including those with myocardial infarction (Oldridge, Streiner, Hoffman, & 
Guyatt, 1994). The short version is recommended for use when there are patient 
limitations such as fatigue, (Shacham, 1983) as can occur following AMI. The brief 
version of the POMS consists of 30 single-word items that measure six dimensions of 
mood. Responses were rated on a 5-point likert type scale with responses ranging from 0 
{not at all) to 4 {extremely). A total score was computed for each measure of mood, with 
higher scores reflecting higher levels of the symptom severity. The POMS Brief takes 
five minutes to complete. 
Test-retest reliability coefficients have ranged from r = 0.65 to r = 0.74 and are 
considered appropriate for assessing emotional states that are transient and expected to 
respond to clinical interventions (Peterson & Headen, 1984). McNair et al. (1971) 
reported internal consistency reliabilities at .90 to .92 for anxiety and .95 for depression 
and adequate convergent and divergent validity of the subscales of the POMS. In a study 
with cancer patients, Baker et al. (2002) evaluated the psychometric properties of the 
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POMS Brief. The internal consistency reliability for the subscales of interest in Baker and 
colleagues' study ranged from .78 to .91. In the same study, correlations of the short form 
of the POMS with other psychosocial measures (the Centre for Epidemiological Studies-
depression scale (CES-D), the Self-rated Karnofsky Performance scale, the Medical 
Outcomes Study (MOS SF-20), and the Bradburn Positive and Negative Affect Scales) 
were examined. The POMS subscale of depression/dejection correlated most highly with 
the CES-D (0.63) and the negative affect subscales of the Bradburn scale (0.52). The 
POMS subscale of fatigue/inertia correlated with the CES-D (0.34) and with the negative 
affect scale (0.34). Similarly, the POMS subscale of tension/anxiety correlated with the 
CES-D (0.49) and with the negative affect scale (0.56). The subscales of 
depression/dejection correlated negatively (-0.20) with the MOS SF-20 physical 
functioning scale and the Self-rated Karnofsky Performance scale. The POMS 
fatigue/inertia subscale correlated negatively with these two psychosocial measures (0.42; 
0.40, respectively) as did the subscale of tension/anxiety (0.08; 0.08, respectively). This 
pattern of correlations provided support for the convergent and divergent validity of the 
subscales of the brief version of the POMS. 
In order to confirm the reliability and validity of the individual measures of mood 
with the population of interest, reliability statistics and factor analysis were conducted on 
the data. Cronbach's alpha scores ranged from .75 (depression/dejection) to .94 
(fatigue/inertia). Factor analysis revealed good to excellent loadings on each of the 
measures of mood (Table 1). 
Insomnia is defined as a chronic inability to sleep or to remain asleep through the 
night and can be caused by a variety of physical and psychological factors (Glanze et al., 
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Table 1 
Psychometric Testing of the Psychological Indicators of Stress 
Mood scale/Items Factor loadings Chronbach's a 




































Difficulty staying asleep .902 
Interference of sleep problems . 890 
Extent of worry about sleep problems . 841 
Difficulty falling asleep . 821 
Satisfied with sleep .808 
Problem waking too early .806 
Noticeability of sleep problems to others .703 
denotes reliability of dimensions of POMS Brief 
denotes reliability of the ISI 
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1992). In this study, insomnia was measured utilizing the Insomnia Severity Index (ISI, 
Morin, 1993). The ISI is a brief and valid tool, which is sensitive to discrete change, and 
is designed to assess the patient's perception of his/her insomnia (Bastien, Valliers, & 
Morin, 2001). The ISI is comprised of seven items that assess the severity of sleep onset 
and sleep maintenance difficulties, satisfaction with current sleep pattern, interference 
with daily functioning, noticeability of impairment related to sleep problems, and the 
degree of stress caused by the sleep problem. Each item is rated on a five-point likert type 
scale and the total score ranges from 0 to 28, with higher scores implying severe levels of 
insomnia. Insomnia is categorized as non-clinically significant insomnia (score = 0-7), 
subthreshold insomnia (score = 8-14), moderately severe insomnia (score = 15-21), and 
severe insomnia (score = 22-28). Bastien et al. (2001) reported adequate internal 
consistency (r = 0.74). Concurrent validity of the ISI was assessed with Pearson's 
correlation coefficients by correlating the ISI scores with the sleep efficiency variables 
obtained from the sleep diary and polysomnography that were also used in the study. The 
size of the correlations between the ISI insomnia categories (subthreshold, moderately 
severe, and severe) and sleep efficiency obtained with the sleep diary ranged from 0.32 to 
0.55 at baseline and from 0.50 to 0.91 at post-test (p <_0.05). Correlations of the ISI 
scores with the sleep efficiency obtained with polysomnography ranged from 0.07 to 0.45 
at pre-test and from 0.23 to 0.45 (p < 0.05) at post-test. 
Table 1 summarizes the psychometric testing of the ISI. Reliability of the 
instrument was demonstrated through a Chronbach's alpha of .92. In addition, factor 
analysis revealed good to excellent loadings of all items in the instrument (.70 to .90). 
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Physiological Outcomes 
The physiological outcomes of interest in this study were length of stay, acute 
cardiac ischemia, cardiac arrhythmia and re-infarction. For the purpose of this study, 
length of stay was defined as the length of CCU hospitalization and was measured in 
terms of the number of days from admission to discharge from the CCU. Acute cardiac 
ischemia refers to inadequate blood supply to the myocardium, which is marked by pain 
and organ dysfunction (Glanze et al., 1992). Acute ischemia was evidenced by frequency 
of new onset chest pain for which nitroglycerin or morphine is administered. Measures of 
this variable were determined through documentation of the administration of either 
medication in the patient record. Arrhythmia is defined as "any change in the normal 
pattern of the heart beat" (Glanze et al, p. 60). Cardiac arrhythmias of interest to this 
study were: (a) sustained ventricular tachycardia requiring pharmacologic or electrical 
intervention, or (b) ventricular fibrillation. Sustained ventricular tachycardia is defined as 
a persistent run of premature ventricular contractions with a rate between 120 to 200 
beats per minute (Thaler, 1995). Ventricular fibrillation is marked by complete lack of a 
regular heart beat generating no cardiac output, and EKG tracings which reveal no true 
QRS complexes (Thaler, 1995). Cardiac arrhythmia was operationalized in terms of the 
frequency of events, as documented in the patient record. Re-infarction is conceptually 
defined in terms of whether the patient experienced an extension of the existing AMI or 
new cardiac necrosis due to a secondary event. A patient was considered to have a re-
infarction if documentation in the medical chart confirmed this occurrence. 
Data Collection 
Prior to data collection, approval of the study protocol was obtained from the 
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Research Ethics Boards of the University of Windsor, Hotel Dieu-Grace Hospital, 
Windsor Regional Hospital and Chatham-Kent Health Alliance. In order to explain the 
study and methodology, the investigator discussed the study with the unit managers and 
staff of the CCU's prior to the start of this study. Two registered nurses (one employed at 
Windsor Regional Hospital and one employed at Chatham-Kent Health Alliance) and one 
nursing student from the University of Windsor were hired and trained to assist with data 
collection. Given that research has suggested that the number and severity of withdrawal 
symptoms peaks on day two (Gritz et al, 1991), data were collected by the researcher 
and/or trained research assistants on the second day following admission to the CCU. 
Guidelines for recruitment of subjects is described in Appendix C. Patients who met the 
inclusion criteria were approached by the researcher or research assistant, given a full 
verbal and written explanation of the study, and were invited to participate. All 
individuals who agreed to participate in the study provided informed consent, thus 
indicating their willingness to participate in the study. Granting permission to review 
medical charts was provided to the researcher by each subject. The subjects' charts were 
reviewed for documentation of data such as, anginal episodes, arrhythmia and re-
infarction (Appendix A). This data was coded to correspond with participant self-reported 
data. In order to verify clarity of response items and length of time needed for 
completion, pre-test of the survey was conducted with a sample of five individuals who 
met the inclusion criteria. As no amendments were required to the protocol, this pre-test 
data was included in the analysis. 
The survey package consisted of a letter from the investigator, a demographic 
data questionnaire, the POMS Brief and the ISI (Appendix A). The assessment 
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package was given to the participants on day 2 after admission to the CCU. Upon 
consenting to participate in the study, the investigator provided participants with verbal 
instructions concerning the completion of the survey. Participants were also provided the 
opportunity to review the questionnaires and ask questions. The researcher or research 
assistant was not present during completion of the questionnaires. Completion time of the 
survey averaged 10 to 15 minutes. In addition to the questionnaires, each participant was 
provided with an unmarked envelope in which to seal their completed questionnaires. 
Completed surveys were returned to the nursing staff, who deposited them in a secured 
drop-box which was provided on each unit. 
Data Screening and Analysis 
Data was analyzed using the Statistical Package for the Social Sciences (SPSS) 
16.0. A two-tailed alpha of .05 was used to determine the significance of statistical 
findings. Prior to data analysis, 20% of the data was randomly checked for accuracy of 
data entry. No errors were found. All collected data were screened for issues with missing 
data, outliers, multicollinearity, singularity and normality. Univariate statistical 
procedures included student t-tests, chi-square analysis and Pearson correlation. 
Multivariate analyses consisted of multivariate analysis of covariance (MANOVA) and 
multivariate analysis of covariance (MANCOVA). A detailed discussion of the screening 
and cleaning of data, and testing of assumptions for each of the aforementioned 
procedures is described in Chapter IV. 
Protection of Human Subjects 
This study conformed to Tri-Council Standards for the ethical conduct of 
research. As previously stated, approval for this study was sought from the Research 
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Ethics Boards of the University of Windsor, Hotel Dieu-Grace Hospital, Windsor 
Regional Hospital and Chatham-Kent Health Alliance. Participants were selected from 
those wishing to participate based upon the inclusion and exclusion criteria. Participants 
were provided copies of the letter of information and informed consent prior to 
participating in the study (Appendix B). In addition, a copy of the information collected 
from the participants' charts was attached to the consent. The consent form included 
information regarding the investigator, purpose of the study, procedures, potential risks 
and benefits, confidentiality and anonymity. A signed consent form was obtained from 
each participant. Patients were assured that their decision to participate or not participate 
did not affect their care in any way. Anonymity of participant response was protected 
through the use of pre-assigned codes on the data collection sheets that did not disclose 
the patients' identity. All hard data is, and will continue to be stored in a locked cabinet. 
This data is accessible only to members of the research team. Electronic data was and is 
saved in a password protected computer program. The data will be kept on file until 
2012. The data may be used for subsequent research studies. Following this date, the hard 




This chapter summarizes the results of the statistical analyses. A description of 
the data screening and cleaning process is provided, followed by a summary of sample 
characteristics. Finally, the analysis associated with each of the three research questions 
is presented. 
Data Screening and Analysis 
When the database was screened for missingness, there were missing data on the 
following items from the psychometric measures of mood: unworthy, sluggish, furious, 
uneasy, interference of sleep problems with daily functioning and noticeability of sleep 
problem to others. These items had one or two missing values each, yielding a total of 10 
missing values. In order to avoid dropping these cases, which would result in a reduction 
in sample size, thus compromising statistical power (Patrician, 2002), case mean 
substitution was used to replace these missing values. This involves replacing a missing 
value with the mean of the remaining items for that case (Raymond, 1986), and is 
considered appropriate for the imputing ordinal missing values in a psychometric Likert-
type scale (El-Masri & Fox-Wasylyshyn, 2005). 
As the focus of this study is to determine the impact of smoking cessation on 
patients with AMI, the variables non-smoker (never smoked) and past-smoker (quit 
greater than one month ago) were collapsed together to form the true representation of the 
variable non-smoker. That is, the literature suggests that the physiological and 
psychological symptoms of withdrawal return to precessation levels 30 days after quitting 
(Hughes, 1992). In addition, as each of the measures of mood was considered an 
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individual indicator of stress, the scores from each item were summed to provide the total 
score on each of the following measures of mood: anxiety, depression, anger, fatigue and 
insomnia. 
Testing of Assumptions 
The univariate statistics used in this study met the following assumptions: absence 
of outliers, normality and linearity. Screening of univariate outliers was performed using 
histograms, box plots and z-score statistics with a cut-off of 3.29. Variables were 
screened for normal distribution using skewness and kurtosis statistics and histograms. 
Given a small study sample, a critical value of + 2.58 was used to evaluate the 
significance of skewness and kurtosis in this study (Stevens, 1996). In all variables with 
outliers, return of such values to next highest value plus 1 resulted in a normal 
distribution of the variable. Histograms and Q-Q plots were used to inspect all continuous 
variables for linearity. As were no occurrences of re-infarction or ventricular fibrillation, 
these variables were not included in the statistical analysis. With the exception of the 
variable, ventricular tachycardia, linearity was achieved in all variables which were 
included in the analysis. Unsuccessful transformation of the variable, ventricular 
tachycardia, resulted in dichotomization of this variable. Tables 2 and 3 summarize the 
testing, results and treatment of the dependent variables. 
The assumptions of MANOVA and MANCOVA include the above, in addition to 
the necessity to meet homogeneity of covariance matrices. That is, the variances in each 
of the groups of interest (smokers and non-smokers) are roughly equal. Furthermore, in 



















































































































































































































































































































































































































































































































































































































































































































































































































variable. Homogeneity of variance was tested for all variables through determination of 
the Levene's statistic. The Levene's test was violated in all of the variables with the 
exception of the variable anger. This was not considered an issue, as interpretation of the 
results for the statistical tests employed take into account the violation of this test. 
Sample Characteristics 
Subjects were recruited from three hospitals, two in Windsor, Ontario (n = 42) 
and one in Chatham, Ontario (n = 18). Of the 60 patients enrolled, 57 cases were valid for 
inclusion in the analysis. The three cases that were deleted from the study had missing 
data which represented greater than 20% of the survey. The mean age of the sample was 
58 years (SD + 10.47). The majority of patients in the sample were diagnosed with their 
first AMI (n = 39; 86%). Fifty-one percent (n = 29) were actively smoking prior to 
admission to the hospital, and 79.3 % (n = 23) of these same participants reported 
experiencing symptoms of withdrawal. The majority of participants reported their 
ethnicity as white (n = 51; 89.5%), with men comprising 71.9% (n = 41) of the sample. 
The mean CCU length of stay was 4.35 days (SD ± 1.63), while the mean number of 
ischemic episodes was 2.89 (SD + 3.56). A summary of the sample characteristics is 
presented in Table 4. 
Research Question 1 
The first research question examined the difference in the psychological 
indicators of stress between smoking and non-smoking AMI patients. The dependent 
variables include measures of tension/anxiety, depression/dejection, anger/hostility, 
fatigue/inertia and insomnia. Following data cleaning, all of the aforementioned variables 
























































































































significant differences between smokers and non-smokers on the anxiety (t = -2.468; p = 
.017), depression (t = -2.\64;p = .035), and anger (t = -4.046;/? = .000). That is, smokers 
reported significantly higher levels of anxiety, depression, and anger than non-smokers 
while hospitalized in the CCU following AMI (Table 5). 
MANOVA was performed to examine the adjusted difference between smokers 
and non-smokers on each of the dependent variables. That is, while holding all else 
constant, MANOVA allows the examination of the mean differences between smokers 
and non-smokers while taking into account the any correlations that might exist between 
the outcome variables. In addition to the univariate assumptions, the following 
assumptions were tested and met prior to analysis: multivariate normal distribution of the 
dependent variables and multivariate homogeneity of covariance matrices (p value for 
Box's M = .350). The Levene's test of homogeneity of variance indicated that the two 
groups had equal variance in all dependent variables (p > .05), except for anger (p < .05). 
However, MANOVA is known for its robustness to violation of homoegeneity of 
variance when the analysis is conducted on equal groups (Tabachnick & Fidell, 1996). 
Given that MANOVA assumes that the outcome variables be correlated, Pearson 
correlation was performed in order to determine the correlations between each of the 
dependent variables. The data suggested that correlations existed among the following 
variables: fatigue, depression, anger, insomnia and anxiety. A correlation matrix 
describing the statistical relationship among the variables is provided in Table 6. 




Summary oft-test Comparisons for the Psychological Indicators of Stress 
Variable M+SD t 



















3.50 + 3.46 
5.76 + 3.45 
3.68 + 3.28 
2.64 + 2.79 
4.59 + 3.27 
4.65 + 3.61 
5.29 + 5.48 
6.69 + 5.31 
6.00 + 5.39 
1.32+1.39 
4.17 + 3.75 
2.95 + 3.41 
10.18 + 7.06 
9.62 + 7.58 







Correlation Matrix of the Relationship Among the Psychological Indicators of Stress 












5. Anxiety .685* .781* .618* .341* 1 
* correlation is significant at < .05 
The findings suggested that after controlling for the correlations among the 
dependent variables, the levels of depression (F = 4.07; p = .034), anxiety (F = 6.09; p 
.017), and anger (F = 8.67; p = .005) of AMI patients were impacted by smoking status. 
That is, smokers had significantly higher levels of depression (M = 4.59 + 3.27), anxiety 
(M = 5.76 + 3.45) and anger (M = 4.17 + 3.75) as compared to the non-smokers (means = 
2.64 + 2.79; 3.50 + 3.46; and 1.32 + 1.39, respectively). However, there was no overall 
multivariate difference between smokers and non-smokers (F = 28.176;/? = .073). In 
addition, the univariate comparisons on depression, anxiety, and anger were identical to 
those obtained from the unadjusted Hest analysis. These results are summarized in 
Tables 7 and 8. 
Multiple analysis of covariance (MANCOVA) was then conducted to determine if 
there were any covariates influencing the impact of smoking status on each of the 
dependent variables. Given that only continuous variables can be included as covariates 
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Table 7 
MANOVA Analysis on the Impact of Smoking on the Psychological Indicators of Stress 
Variable M+SD F p 














3.50 + 3.46 
5.76 + 3.45 
2.64 + 2.79 
4.59 + 3.27 
1.32 ±1.39 
4.17 + 3.75 
5.29 + 5.48 
6.69 + 5.31 
10.18 + 7.06 





in MANCOVA, univariate analysis was conducted on the continuous variables that 
conceptually may have had a confounding effect on the psychological indicators of stress. 
The results of the analysis demonstrated that age was the only potential confounder. As a 
result, MANCOVA was performed to determine the effect of smoking cessation on each 
of the measures of mood while adjusting for age. The findings suggested that after 
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adjusting for age, there was an overall multivariate difference between smokers and non-
smokers (F = 3.128;/? = .016). Furthermore, the levels of depression (F = 4.814;/? = 
.033), anxiety ( F - 7.991;/? .007), and anger (F = 6.125;/? - .017) of AMI patients were 
impacted by smoking status. That is, smokers had significantly higher levels of 
depression (M = 4.59 + 3.27), anxiety (M = 5.76 + 3.45) and anger (M = 4.17 + 3.75) as 
compared to the non-smokers (means = 2.64 + 2.79; 3.50 + 3.46; and 1.32 + 1.39, 
respectively). These results are summarized in Tables 8 and 9. 
Table 8 
Multivariate MANCOVA Results for Smoking and Age 




Depression Smoking .762 3.128 .016 
Anger 




Post-hoc Univariate MANCOVA Comparisons After Adjusting for Age 
















3.50 + 3.46 
5.76 + 3.45 
2.64 + 2.79 
4.59 + 3.27 
1.32+1.39 
4.17 + 3.75 
5.29 + 5.48 
6.69 + 5.31 
10.18 + 7.06 






Research Question 2 
The second research question was aimed at determining the differences in the 
functional outcomes of smoking and non-smoking AMI patients following AMI, as 
measured by length of stay, arrhythmia, re-infarction and cardiac ischemia. As there were 
no occurrences of re-infarction in the study, statistical analysis was not conducted on this 
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variable. Furthermore, after exploring the variable arrythmia, there were no episodes of 
ventricular fibrillation in either the smoking or the non-smoking group. Therefore 
analysis was conducted on the variable ventricular tachycardia only. 
Student Mest comparisons were conducted on the continuous outcome variables 
(length of stay and cardiac ischemia). Prior to analysis, all assumptions of the statistical 
test were verified as being met. The data suggested that there were no significant 
differences between smoking and non-smoking AMI patients with respect to length of 
stay in the CCU (4.34 and 4.36 days; t = .028; p = .978) and episodes of cardiac ischemia 
(2.38 and 3.43 episodes; t=l.ll;p = .272). 
Given that the variable, ventricular tachycardia was dichotomized, chi square 
analysis was conducted to determine if there was a difference in the occurrence of 
ventricular tachycardia among AMI patients who reported smoking prior to admission 
and those who reported non-smoking. The data suggested that there was no difference in 
episodes of ventricular tachycardia among smokers and non-smokers (%2 = .073; p = 
.786). 
MANO VA was not performed on the physiological indicators of stress because 
Pearson correlation demonstrated that the variables length of stay and cardiac ischemia 
were not correlated (r = . 142; p = .293). 
Research Question 3 
The third research question examined the relationships between the physiological 
indicators of stress and the psychological well-being of smokers and non-smokers 
following AMI. Given that all variables, except for the variable ventricular tachycardia, 
were measured as continuous variables, two statistical tests were conducted. First, 
55 
Pearson moment correlation was performed to explore the correlations among the 
continuous variables: length of stay, cardiac ischemia, depression, anxiety, anger, fatigue 
and insomnia. Next, the differences in the psychological indicators of stress between 
those who experienced ventricular tachycardia versus those who did not were explored 
through the use of student Mests. Pearson moment correlation revealed that there was 
only one statistically significant relationship among the psychological and physiological 
indicators of stress. That is, the variables, insomnia and ischemia were significantly 
correlated (r = .289; p = .029). The correlation matrix in Table 10 displays all correlation 
coefficients of the explored associations. . 
Finally, the results of the r-tests suggested that there was no significant difference 
between those who experienced ventricular tachycardia versus those who did not on any 
of the psychological measures of mood. That is, depression (t = .155;/? = .878), anxiety (t 
= 382; p = .704), anger (f = -.154;/? = .878), fatigue (f = -.681;/? = .498), and insomnia (t 
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T-test Comparisons: Ventricular Tachycardia (Vtach) and Psychological Measures 
Variable M + S D t p 
Anxiety 
Experienced vtach 4.74 + 3.62 .382 .704 
Did not experience vtach 4.27 + 3.72 
Depression 
Experienced vtach 3.72 + 3.28 .155 .878 
Did not experience vtach 3.54 + 3.47 
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Variable M+SD t p 
Anger 
Experienced vtach 2.91 + 3.36 -.154 .878 
Did not experience vtach 3.09 + 3.75 
Fatigue 
Experienced vtach 5.76 + 5.42 -.681 .498 
Did not experience vtach 7.00 + 5.42 
Insomnia 
Experienced vtach 9.89 + 7.57 -.007 .994 




This chapter presents a discussion of the study results. Each research question will 
be examined individually, with a focus on: (a) degree of fit with the theoretical 
framework, and (b) congruence and/or lack of congruence with the existing literature. 
Implications for nursing research and nursing practice will be provided, followed by 
limitations of the study. This section will conclude with a summary of the discussion. 
Research Question 1 
The first research question examined the difference in the psychological 
indicators of stress between smoking and non-smoking AMI patients. The model adapted 
for the study (Lazarus & Folkman, 1984) posited that smokers who were unable to use 
smoking as a coping effort would experience higher levels of stress (as measured by 
depression, anxiety, anger, fatigue, and insomnia) than non-smokers. Overall, the 
findings supported this supposition. That is, smokers reported higher levels of depression, 
anxiety, and anger than non-smokers. This is not surprising given that several researchers 
reported these mood states to be typical symptoms of nicotine withdrawal (Gritz et al., 
1991; Tsuda et al., 1996; VanderKaay & Patterson, 2006). However, there were no 
differences between smokers and non-smokers with respect to fatigue and insomnia. The 
outcomes associated with each of the measures of mood are discussed individually in the 
following text. 
The Impact of Smoking Cessation on Anxiety 
The findings of this study support those of other previous researchers who 
reported higher levels of anxiety among individuals who experience abrupt nicotine 
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withdrawal (Gritz et al., 1991; Hughes, 1992; VanderKaay & Patterson, 2006). In fact, 
although anxiety was highly correlated with both depression and anger, these patients had 
higher levels of anxiety even after adjusting for depression and anger. This finding 
supports the notion that smokers will likely experience increased levels of anxiety when 
hospitalized for AMI. This may be due to a combination of the physiological effects of 
nicotine withdrawal and a variety of psychological factors. Current standard of care is to 
administer anti-anxiety medications to patients who are having difficulty coping with the 
symptoms of nicotine withdrawal and/or the experience of AMI. Although the use of 
MANCOVA in this study did not allow for the control of categorical data (covariates can 
only be continuous variables), it is important to note that more smokers (66%; n = 19) 
received anti-anxiety medications, as compared to non-smokers (46.4%; n - 13), lending 
further support to the study findings. 
As previously stated, it is possible that the anxiety experienced by smokers 
following AMI is also due to psychological factors. For example, the symptoms of 
anxiety may be exacerbated by fear of ability to successfully quit smoking. In this study, 
almost 90% (« = 26) of smokers indicated definite plans to quit smoking in the next 
month, yet 93% (n = 27) had been unsuccessful in past attempts. In fact, 54% (n = 15) 
reported having had three or more unsuccessful quit attempts in the past. Given that 
patients have reported smoking as a causal factor in AMI (Clark, 2003; Condon & 
McCarthy, 2006; Fukuoka et al., 2004; King, 2002; McKibbin & Wilson, 2001), it is 
therefore likely that past failed attempts may contribute to increased anxiety among 
smokers who experience AMI. That is, when a smoker identifies smoking as a cause of 
his/her AMI and reflects upon past unsuccessful quit attempts, these processes may 
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combine to produce greater stress among this group of smokers than smokers who have 
not previously attempted to quit smoking. Furthermore, with the exception of enforced 
smoking cessation, it may be assumed that the stressors associated with AMI are similar 
for both smokers and non-smokers. These stressors may include fear of death, lifestyle 
modifications and impact on job and/or family. In the case of a non-smoker, he or she 
may still be able to utilize his or her usual coping strategies in the CCU environment. 
However, smokers are unable to rely upon smoking as means of coping, and this may 
heighten the anxiety associated with the experience of AMI. 
The Impact of Smoking Cessation on Depression 
The findings of this study suggest that smokers had higher depression scores than 
non-smokers. These findings are congruent with research literature that suggests 
depression is a symptom of smoking withdrawal (Hughes, 1992; VanderKaay & 
Patterson, 2006). In fact, Hughes found a correlation between cigarette craving and 
depression. More importantly, the results of this study revealed that smokers experienced 
higher levels of depression, regardless of their levels of anxiety and/or anger. 
Interestingly, Kuhn (1996) reported a converse relationship between smoking cessation 
and depression, wherein smokers experienced lower depressive symptomatology than 
non-smokers following AMI. Kuhn hypothesized that non-smokers were searching for a 
reason for their AMI, whereas smokers had an identified cause and were therefore less 
depressed. This hypothesis is yet to be validated in any existing literature. Furthermore, it 
must be noted that Kuhn's study was limited by two methodological concerns: (a) smaller 
sample size (n - 40); and (b) data collection procedures that occurred over an extended 
period from hospitalization to post-discharge, in which case, control over smoking status 
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was not maintained. In addition, time of data collection was not consistent with peak 
withdrawal, which occurs in the first two days following smoking cessation (Gritz et al., 
1991; Hughes, 1992). 
As previously suggested, depression among smokers is likely related to the 
physiological result of nicotine withdrawal and a combination of other psychological 
factors. Specifically, it is possible that an individual who smokes may experience higher 
levels of depression due to apprehension and/or worry concerning his/her ability to 
successfully quit. Although the full impact of these psychological factors on the 
depression scores of smokers is not known, the methodology and statistical techniques 
employed in this study likely provide sufficient evidence to support the findings. That is, 
smokers experienced higher levels of depression and this is most probably due to abrupt 
smoking cessation. Further research in this area is warranted to fully examine the 
relationship between smoking cessation and depression in this population. 
The Impact of Smoking Cessation on Anger 
In this study, smokers reported significantly higher levels of anger than non-
smokers. This finding is congruent with those of several researchers who reported an 
association between anger and smoking status (Hughes 1992; Tsuda et al., 2006; 
VanderKaay & Patterson, 2006). In particular, these researchers attributed anger to abrupt 
withdrawal from nicotine. Although smokers in this thesis study were subjected to abrupt 
smoking cessation, there were likely other factors that also contributed to their increased 
levels of anger. For example, given that patients have attributed smoking as a causal 
factor in AMI (Clark, 2003; Condon & McCarthy, 2006; Fukuoka et al., 2004; King, 
2002; McKibbin & Wilson, 2001), it is possible that smokers experience resentment 
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towards their current smoking behaviours. In addition, it may be hypothesized that these 
feelings of anger are heightened by prior unsuccessful quit attempts. 
The Impact of Smoking Cessation on Fatigue 
The data suggested no association between fatigue and abrupt nicotine 
withdrawal, a relationship that has not been investigated in previous research. This 
finding may be explained by the fact that almost half (n = 27) of the study participants 
received sedation while hospitalized in the CCU. In fact, the results showed that an 
interesting 55% (n = 16) of smokers were sedated as compared to 39% (n = 11) of non-
smokers. Given that more smokers received sedation as compared to non-smokers, it may 
follow that if sedation could be held constant, smokers may actually experience more 
fatigue than non-smokers. Unfortunately, MANCOVA assumptions did not allow for 
inclusion of this categorical variable as a covariate. 
The Impact of Smoking Cessation on Insomnia 
Contrary to VanderKaay and Patterson (2006) who reported insomnia as a 
symptom of nicotine withdrawal, the findings of this study suggested no difference 
between smokers and non-smokers with regard to their insomnia. Although the 
theoretical model (Lazarus & Folkman, 1984) proposed that smokers and non-smokers 
would differ with regard to insomnia, it is likely that this relationship was masked by the 
administration of sedation. As previously presented, sedation was administered to almost 
half of the patients in this study (47%; n = 27), 60% of whom were smokers. 
Research Question 2 
The data did not support a difference in the functional outcomes of smokers and 
non-smokers when hospitalized with AMI. These results do not fit the propositions of 
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Lazarus and Folkman's (1984) Transactional Model of Stress and Coping. This model 
suggests that smokers who are unable to use smoking as a coping strategy will experience 
different functional outcomes as compared to non-smokers. In this study, smokers and 
non-smokers did not differ with regard to CCU length of stay, episodes of cardiac 
ischemia, arrhythmia or re-infarction. In fact, no participants experienced either re-
infarction or ventricular fibrillation. These findings contradict that of Mayou et al. (2000) 
who reported a relationship between distress and longer hospital stay. There are a variety 
of reasons to explain this inconsistency in the findings. First, it is important to note that 
Mayou and colleagues published no supporting data for this result, and therefore 
Mayou's findings must be questioned. Second, this study examined length of stay in the 
CCU only, while Mayou et al. studied the impact of stress on total hospital stay. It is 
possible that symptoms of distress increase after transfer from the CCU because patients 
no longer receive the same level of individualized care as provided in the CCU. Thus, the 
impact of smoking cessation on length of stay may be better measured by total length of 
hospital stay. Third, length of stay in CCU is likely attributed to additional factors which 
were not considered in the study. Specifically, bed availability on a telemetry unit often 
determines when AMI patients are transferred from the CCU. Furthermore, AMI patients 
often undergo cardiac catheterization, which may delay transfer to a step-down unit. 
There are no known studies which have examined the direct impact of smoking 
cessation on the physiological impact of AMI patients. However, Moser and Dracup 
(1996) reported that anxiety predicted cardiac complications, such as cardiac ischemia, 
ventricular fibrillation and re-infarction, among hospitalized AMI patients. These 
findings were not supported by this study. Nevertheless, it must be noted that Moser and 
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Dracup's findings represent an indirect relationship between smoking status and 
functional outcomes. Furthermore, Moser and Dracup's study was conducted on a 
relatively larger sample (N= 86), which may have provided the statistical power required 
to detect differences between the groups. In addition, it is possible that anxiety levels 
among participants in this study were not high enough to impact the physical outcomes. 
This may be explained by the fact that the 56% (n = 32) patients in this study received 
anxiolytics. Data were collected with respect to such medications, however, given that 
they were categorical variables, they could not be included as a covariate in the analysis. 
Furthermore, ischemia was measured through administration of either morphine or 
nitroglycerin on an as needed basis. It is important to note that it is standard practice in a 
CCU to administer nitroglycerin intravenously to control ischemia in a patient who 
continues to experience frequent symptoms of angina. Hence, all episodes of cardiac 
ischemia may not have been accounted for. 
Research Question 3 
The Transactional Model of Stress and Coping (Lazarus & Folkman, 1984) 
proposed a relationship between the psychological and physiological indicators of stress. 
In this study, AMI patients who experienced cardiac ischemia also experienced insomnia. 
This is likely explained by two presumptions: (a) either these patients were awakened by 
the discomfort associated with angina; or (b) these patients were troubled by the 
possibility of experiencing angina, and therefore, experienced sleep disturbances. 
Although the model proposed a relationship among the remaining variables, there were 
no other significant relationships between the psychological and functional outcomes. 
These findings were incongruent with the findings of Moser and Dracup (1996) who 
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reported a significant relationship between high anxiety levels, ischemia, re-infarction 
and ventricular fibrillation. However, it is important to note that Moser and Dracup's 
study was published in 1996 and that the treatment of patients experiencing AMI has 
progressed since that time. In this study, no participants experienced any episodes of re-
infarction or ventricular fibrillation. 
Implications 
Implications for Nursing Practice 
This is a pilot study that was conducted on a relatively small sample. Thus, it is 
difficult to infer that the findings of this study provide prescription for practice. However, 
the findings of this study suggest the need for nurses to fully assess and intervene to meet 
the emotional needs of their AMI patients. Given that psychological distress among AMI 
patients is associated with mortality (Ariyo et al., 2000; Frasure-Smith et al., 1993; Grace 
et al., 2005), in-hospital complications (Moser & Dracup, 1996), and subsequent distress 
(Bennett et al., 1999; Brown & Mumford, 1984; Chalfont and Bennett, 1999; Lowe et al., 
2000; Mayou et al, 2000), the importance of reducing psychological stress among AMI 
patients is essential. More importantly, this study highlights the need for ongoing 
assessment and treatment of anxiety, depression, and anger among AMI patients who are 
experiencing nicotine withdrawal symptoms. Although it is common for such patients to 
receive anti-anxiolytics medications to reduce anxiety, only 65.5% (n = 19) received such 
medications. This is concerning given that 79.3% (n = 23) of smokers reported 
experiencing one or more symptoms of nicotine withdrawal. Currently, it is not common 
for AMI patients to receive nicotine replacement or pharmacological smoking cessation 
aids in the initial phase following AMI. Thus, it may be useful to recommend that 
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consideration be made with regard to the efficacy and safety of such aids in this patient 
population. This is especially important given that high stress may hamper smoking 
cessation (Brown & Mumford; Rose etal., 1994). Therefore, not intervening may create a 
cyclical pattern of stress, leading to further stress and the inability to successfully quit, all 
of which may increase the mortality associated with cardiovascular disease. 
Although no physiological complications associated with nicotine withdrawal 
were found in this study, previous research (Moser & Dracup, 1996) suggests that this 
relationship exists. This may be attributed to the small sample of this study. Thus, it is 
important that this association be further investigated, and that diligent assessment of 
complications among smokers who experience AMI continues. 
Implications for Nursing Research 
The findings of this study highlight the need for further research related to the 
impact of abrupt smoking cessation among hospitalized AMI patients. First, replication 
of this study with a larger sample is important to validate the findings. To better 
understand the relationship between smoking and length of stay, replication of this study 
examining the total length of hospitalization from admission to discharge is 
recommended. Given that only 29% of participants in the study were women, it is 
difficult to infer any conclusions related to gender differences and smoking cessation 
following AMI. Therefore, further research is recommended to more fully understand any 
relationships that might exist. 
Although the impact of abrupt nicotine withdrawal on the mood of individuals 
who smoke is well reported in the literature, less is known about smokers who are 
hospitalized for AMI. Furthermore, the psychological factors which may enhance the 
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distress of hospitalized AMI patients who smoke are even less understood. Thus, it is 
important that further studies examining this relationship be conducted to develop a 
complete understanding of the impact of smoking cessation on mood. Attention should be 
given to smoking history, specifically the desire to quit smoking and the number of 
previous quit attempts. Finally, the results of this study lend support for intervention 
research to determine the efficacy and appropriateness of smoking cessation aids for 
smokers who are hospitalized with AMI. Such a study could also examine the 
longitudinal impact of early intervention on quit success, as well as the mortality of 
cardiac patients who smoked prior to experiencing AMI. 
Implications for Nursing Education 
This study offers implications for both the education of nurses and patients. It is 
prudent that critical care curricula and institutional orientation programs for nurses 
working with cardiac populations include content related to smoking cessation and AMI. 
That is, nurses need to recognize the possible impact of abrupt nicotine withdrawal on the 
psychological and physiological stress of AMI patients. Furthermore, health care 
professionals require education related to the management of symptoms of nicotine 
withdrawal in this population. 
Regarding patient education, nurses should instruct smokers who are experiencing 
AMI that symptoms of anxiety, depression, and anger are possible after experiencing a 
heart attack and that it is essential that patients recognize these symptoms and report them 
to the health care team. From a health promotion perspective, education concerning the 
risks associated with nicotine use is paramount. Specifically, this education should 
include the risk factors associated with mood changes and possible complications that 
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may occur following AMI. This represents additional information that may inhibit 
initiation of smoking, or promote smoking cessation among patients prior to experiencing 
an AMI. 
Limitations 
Although this study adds to the empirical evidence regarding the impact of 
smoking cessation on patients who experience AMI, it is not without limitations. These 
limitations can be summarized by issues related to the following: (a) sample size; (b) 
statistical restrictions; (c) the observational nature of the study, and (d) recruitment 
issues. Although the study was pilot in nature, 57 participants is likely not sufficient to 
provide significant power to detect the full impact of smoking cessation on this 
population. However, despite the relatively small sample, the findings suggested that 
smoking cessation has a negative impact of the psychological indicators of stress among 
AMI patients. 
The choice of statistical application limited the testing of possible confounding 
variables in the relationships. That is, there were several variables for which data was 
collected that may have possibly confounded the relationships among the variables. 
Unfortunately, MANCOVA requires that covariates are continuous variables. Therefore, 
the statistical procedures were unable to control for the possible impact of such variables 
as, medications, smoking history, cardiac catheterization and previous AMI on the 
outcome variables. Given the observational nature of the study, no causality could be 
inferred. In addition, the self report nature of responses introduces a potential for 
response bias. Finally, the demographic characteristics of the study population may limit 
the generalizability of the results. Although the intent was to recruit participants from a 
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variety of racial and socio-economic groups, this study included participants who were 
primarily Caucasian. This may be attributed to the fact that the inclusion criteria required 
that participants possess the ability to read and understand English. Therefore, it is 
possible that this criterion limited the number of subjects from non-traditional ethnic 
groups who were otherwise eligible to participate: Furthermore, given that the majority of 
participants were male, the impact of abrupt smoking cessation on females is not fully 
understood. 
Conclusions 
The purpose of this study was to develop a better understanding of the impact of 
abrupt smoking cessation on patients who experience AMI. The findings suggest 
congruence with some of the relationships between the concepts in the adapted 
theoretical framework. Overall, smoking status did significantly impact the psychological 
stress of AMI patients, but did not appear to impact the functional outcomes of this 
population. In addition, there was only one significant relationship between the 
psychological and physiological indicators of stress. The discussion addressed the issues 
related to the significant findings and provided plausible explanations for the non-
significant results. This study offers noteworthy implications for theory development, 
nursing practice, education and research. In light of the limitations of this study, it is 
recommended that further investigation be conducted. 
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APPENDIX A 
Data Collection Forms 
Dear Participant, 
This survey is designed to better understand your stress levels after the 
experience of your heart attack and whether smoking cessation due to 
hospital admission has an impact on these stress levels. The survey consists 
of three parts: the Profile of Mood States, and the Insomnia Severity of 
Index, and a questionnaire that asks information about your health and 
smoking status. Please follow the instructions that are included at the 
beginning of each questionnaire and complete them as best fits your 
experience since being hospitalized. Please note that in this study, smoking 
refers to the use of any nicotine product, such as cigarettes, cigars, pipes 
and/or chewing tobacco. 
When you have completed all three parts of the survey, please seal all three 
of your answer sheets in the provided envelope. Once you do that, you may 
ask one of the nurses in the unit to place the envelope in the secured box that 
I will make available on the unit. Envelopes deposited in the box will be 
collected by a member of the research team at a later time. 
Thank you for taking the time to participate in this study. 
KathyPfaff,RN,BScN 
Master's Student Investigator 
University of Windsor 
Faculty of Nursing 
71 
Profile of Mood States Brief 
Instructions: 
Below is a list of words that describe feelings that people have. Please read each word 











































© McNair, Lorr., & Droppelman, 1992 
This represents six items of the 30 item POMS Brief. Written permission to use the 
POMS Brief and to publish these items was granted by the publisher (Multi-Health 
Systems Inc.). 
72 
Insomnia Severity Index (ISO 
For each question below, please circle the number corresponding most accurately to 
your sleep patterns since being in the hospital. 
For the first three questions, please rate the SEVERITY of your sleep difficulties. 
1. Difficulty falling asleep: 
None Mild Moderate Severe Very Severe 
0 1 2 3 4 
2. Difficulty staying asleep: 
None Mild Moderate Severe Very Severe 
0 1 2 3 4 
3. Problem waking up too early in the morning: 
None Mjld Moderate Severe Very Severe 
0 1 2 3 4 
4. How SATISFIED/dissatisfied are you with your current sleep pattern? 
Very Very 
Satisfied Satisfied Neutral Dissatisfied Dissatisfied 
0 1 2 3 4 
5. To what extent do you consider your sleep problem to INTERFERE with 
your daily functioning (e.g., daytime fatigue, ability to function at work/daily 
chores, concentration, memory, mood). 
Not at all A Little Somewhat Much Very Much 
Interfering Interfering Interfering Interfering Interfering 
0 1 2 3 4 
6. How NOTICEABLE to others do you think your sleeping problem is in terms of 
impairing the quality of your life? 
Not at all A little Somewhat Much Very Much 
Noticeable Noticeable Noticeable Noticeable Noticeable 
0 1 2 3 4 
7. How WORRIED/distressed are you about your current sleep problem? 
Not at all A Little Somewhat Much Very Much 
0 1 2 3 4 
©Morin, C M . (1993, 1996, 2000, 2006). 
Used and published with written permission of the author. 
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Demographic and General Information 
1. Please indicate your age 
years 
2. Gender 
Dmale • female 
3. Ethnicity 
D white D black 
D asian D aboriginal 
• Hispanic D other 
4. Marital Status 
D married D single D widowed 
• divorced/separated • common-
law 
5. Employment Status 




Children at home 
Dyes Dno 
7. Education 
• high school or less D community college/diploma 
• graduate degree 
D university degree 
8. Current Medical Conditions 
D high blood pressure D diabetes • stroke • angina (chest pain) 
D lung disease D cancer D anxiety disorder D depression 
• heart failure 
9. Have you had more than one heart attack? 
D yes D no D I don't know 
*If your answer is no, or you don't know, please skip to question #12 
10. Including this heart attack, how many heart attacks have you had? 
D two D three D more than three 
11. Besides this heart attack, when was your last heart attack? 
D less than one month ago D 1-6 months ago • 6 months to one year ago 
D between one year and 5 years ago D greater than 5 years ago 
74 
12. Have you ever had angioplasty? 
• Yes D No DI don't know 
13. Have you ever had heart bypass surgery? 
D Yes D No 
14. Do you have a family history of heart disease? 
D Yes D No D I don't know 
15. Have you ever been admitted to hospital before? 
D Yes D No 
If yes, how long ago were you in the hospital? 
• less than one month • 1-6 months D 6 months to one year 
D between one year and 5 years • greater than 5 years 
How long were you hospitalized? 
D one day • 2 to 3 days • 4 to 7 days • greater than 7 days 
16. Please indicate your current smoking status before this hospitalization. 
D smoker D non-smoker D past smoker 
* If you are a past smoker, please skip to question #23 
*If you have never smoked, please skip to question #25 
17. What do you smoke? 
D cigarettes • cigars D pipe • chewing tobacco 
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18. On average, how many nicotine products (i.e. cigarettes, chewing tobacco) do 
you use in a day? 
Done D2to3 D4to6 • 7 to 10 • 11 to 20 • greater than 20 
19. When did you last use a nicotine product? 
• 2 days ago D 3 to 6 days ago D 1 to 2 weeks ago 
D greater than 2 weeks but less than one month ago D one month or more ago 
20. Have you ever tried to quit smoking? 
D Yes D No 
If yes, how many times have you tried? 
Dl D2 D3 • 4 or more 
If yes, what strategies did you use to help you quit? 
• none • nicotine patch D nicotine gum 
• medications D counseling • support group 
21. If still smoking, do you plan to quit smoking? 
D No, I am not thinking about quitting 
D I am seriously thinking about quitting in the next 6 months 
• I have made definite plans to quit in the next month 
22. If you have already quit smoking, how long ago did you quit? 
D less than 1 week D 1 to 4 weeks • 1 month to 6 months 
U 6 months to 1 year D more than 1 year 
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What strategies did you use to quit? 
D none D nicotine gum 
D nicotine patches D medication D counseling 
23. Are you experiencing any of the following withdrawal symptoms since your 
hospitalization? 
• irritability D difficulty sleeping • fatigue • difficulty concentrating D headache 
D dry mouth D tightness in chest • sore throat • cough D none 
24. Does your spouse or significant other smoke? 
DYes DNo 
Thank you for your participation. 
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Chart Data Form 
1. CCU Length of Stay 
Admission date to CCU 
Discharge date from CCU 
2. Peak Troponin level 
3. Vital Signs 
Blood pressure 1) on admission 2) at data collection 
Heart rate 1) on admission 2) at data collection 
4. Cardiac Ischemia 
Number of events for which nitroglycerin or morphine was adrninistered 
5. Reinfarcrion 
• yes D no 
6. Arrhythmia 
No. of episodes of ventricular tachycardia 





D beta blocker 
D ACE inhibitor 
D Nicotine replacement 
8. Cardiac catheterization 
D yes D no 
9. CCU Accommodation 
D private room • semi-private room 
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APPENDIX B 
Consent/Letter of Information 
WINDSOR 
CONSENT TO PARTICIPATE IN RESEARCH 
Title of Study: Examining the Physiological and Psychological Impact of 
Smoking Cessation on Patients with Acute Myocardial Infarction (AMI): A 
Comparison of Smokers and Non-Smokers 
You are asked to participate in a research study conducted by Kathryn Pfaff, a 
registered nurse who is also a Master's student in Nursing, and her faculty 
advisor, Dr. Maher El-Masri, from the Faculty of Nursing at the University of 
Windsor. The findings of this study will be used to partially fulfil the requirements 
for Kathryn Pfaff s Master's degree. 
If you have any questions or concerns about the research, please feel to contact 
Kathy Pfaff at (XXX) XXX-XXXX or Dr. El-Masri at (519) 253-3000, ext. 2400. 
PURPOSE OF THE STUDY 
The purpose of this study is to learn more about how smoking withdrawal 
influences the stress levels of people who have experienced an acute myocardial 
infarction (heart attack). 
PROCEDURES 
If you volunteer to participate in this study, we would ask you to do the following 
things: 
1. Report your current smoking status (smoker or non-smoker) to the 
research team. 
2. Complete a 20 minute survey package which will be explained to you by a 
member of the research team. You will be asked to record your answers 
on a form. The interview will take place at the hospital 2 days after your 
admission. The survey package consists to three questionnaires: 
The first asks questions about your stress levels during your 
hospitalization; the second asks questions about your sleeping patterns; 
and the third asks questions about your medical and smoking history 
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3. Agree to allow a member of the research team to gather some 
information about your medical history from your medical record. 
POTENTIAL RISKS AND DISCOMFORTS 
The risks associated with participating in this study are minimal. That is, the risks 
or discomforts are similar to those that a heart patient would experience in the 
period of time following a heart attack. Because heart patients often experience 
fatigue or tiredness following a heart attack, completion of the survey package 
may contribute to this feeling of fatigue. If this occurs, you may complete the 
survey package as your energy level permits. In addition, it is possible that an 
awareness of stress, and/or smoking withdrawal symptoms may increase your 
stress. All patients in a CCU are monitored for the physical and emotional 
complications of increased stress following a heart attack. You are advised to 
report any symptoms of increased stress, such as anxiety, depression, chest 
pain or other heart symptoms to the CCU staff. Finally, it is possible that you may 
find some questions to be personal and/or troubling to you. You may choose to 
not answer any question(s) that you feel is too intrusive and you may withdraw 
from participation at any time without any penalty. There may also be risks or 
discomforts involved in taking part of this study that are not known to the 
researchers at this time. 
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
It is unlikely that you will experience any direct health benefits by participating in 
this study. However, it is hoped that you will feel some satisfaction in knowing 
that you have added to the knowledge that health professionals have about how 
smoking withdrawal affects the physical and emotional health of heart attack 
patients. It is also hoped that the knowleged gained from this study will assist 
health care professionals to better address the stress of patients who are 
hospitalized for AMI. The results of this study may assist nurses to develop 
strategies to reduce the stress associated with sudden smoking withdrawal 
following heart attack. Reductions in stress may hopefully reduce the number of 
complications and deaths that occur from heart attacks. Furthermore, reporting of 
the results of this study may serve as an incentive for those who smoke to quit 
smoking. Finally, the results of this study may provide support for further 
research studies which test the best types of smoking cessation strategies for 
heart attack patients when they are hospitalized. 
PAYMENT FOR PARTICIPATION 
You will not receive any payment for participating in this study. 
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CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can be 
identified with you will remain confidential and will be disclosed only with your 
permission. All hard copies of your data will be stored in a locked cabinet in the 
researcher's office. Data will be kept for 5 years for possible use in future studies, 
following which, the data will be shredded. 
PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not. If you volunteer to be in this 
study, you may withdraw at any time without consequences of any kind. The 
care and treatment that you receive will not be affected if you choose not to 
participate in the study. You may also refuse to answer any questions you don't 
want to answer and still remain in the study. The investigator may withdraw you 
from this research if circumstances arise which warrant doing so. You may also 
choose to withdraw your information from the study. 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS 
The research findings will be published on the Research Ethics Board website at 
the University of Windsor (www.uwindsor.ca/reb). You may also contact Kathy 
Pfaff directly (519-735-3522 or kpfaff@uwindsor.ca) for final results of the study. 
SUBSEQUENT USE OF DATA 
This data may be used in future studies. 
RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your consent at any time and discontinue participation without 
penalty. If you have questions regarding your rights as a research subject, 
contact: 
Research Ethics Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4; 
telephone: 519-253-3000, ext. 3916; e-mail: lbunn@uwindsor 
SIGNATURE OF RESEARCH SUBJECT 
I understand the information provided for the study Examining the 
Physiological and Psychological Impact of Smoking Cessation on Patients 
with Acute Myocardial Infarction: A Comparison of Smokers and Smokers 
as described herein. My questions have been answered to my satisfaction, and I 
agree to participate in this study. I have been given a copy of this form. 
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Name of Subject 
Signature of Subject Date 
SIGNATURE OF INVESTIGATOR 
These are the terms under which I will conduct research. 
Name of Investigator 




LETTER OF INFORMATION FOR CONSENT TO PARTICIPATE IN 
RESEARCH 
Title of Study: Examining the Physiological and Psychological Impact of 
Smoking Cessation on Patients with Acute Myocardial Infarction (AMI): 
A Comparison of Smokers and Non-smokers 
You are asked to participate in a research study conducted by Kathryn Pfaff RN 
and Master's student in Nursing, and her faculty advisor, Dr. Maher El-Masri, 
from the Faculty of Nursing at the University of Windsor. The findings of this 
study will be used to partially fulfil the requirements for Kathryn Pfaff s Master's 
degree. 
If you have any questions or concerns about the research, please feel to contact 
Kathy Pfaff at (XXX) XXX-XXXX or Dr. El-Masri at (519) 253-3000. 
PURPOSE OF THE STUDY 
The purpose of this study is to learn more about how smoking withdrawal 
influences the stress levels of people who have experienced an acute myocardial 
infarction (heart attack). 
PROCEDURES 
If you volunteer to participate in this study, we would ask you to do the following 
things: 
1. Report your current smoking status (smoker or non-smoker) to the 
research team. 
2. Complete a 20 minute survey package which will be explained to you by a 
member of the research team. You will be asked to record your answers 
on a form. The interview will take place at the hospital 2 days after your 
admission. The survey package consists of three questionnaires: The first 
asks questions about your stress levels during your hospitalization; the 
second asks questions about your sleeping patterns; and the third asks 
questions about your medical and smoking history. 
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3. Agree to allow a member of the research team to gather some information 
about your medical history from your medical record. 
POTENTIAL RISKS AND DISCOMFORTS 
The risks associated with participating in this study are minimal. That is, the risks 
or discomforts are similar to those that a heart patient would experience in the 
period of time following a heart attack. Because heart patients often experience 
fatigue or tiredness following a heart attack, completion of the survey package 
may contribute to this feeling of fatigue. If this occurs, you may complete the 
survey package as your energy level permits. In addition, it is possible that an 
awareness of stress, and/or smoking withdrawal symptoms may increase your 
stress. All patients in a CCU are monitored for the physical and emotional 
complications of increased stress following a heart attack. You are advised to 
report any symptoms of increased stress, such as anxiety, depression, chest 
pain or other heart symptoms to the CCU staff. Finally, it is possible that you may 
find some questions to be personal and/or troubling to you. You may choose to 
not answer any question(s) that you feel is too intrusive and you may withdraw 
from participation at any time without any penalty. There may also be risks or 
discomforts involved in taking part of this study that are not known to the 
researchers at this time. 
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
It is unlikely that you will experience any direct health benefits by participating in 
this study. However, it is hoped that you will feel some satisfaction in knowing 
that you have added to the knowledge that health professionals have about how 
smoking withdrawal affects the physical and emotional health of heart attack 
patients. It is also hoped that the knowleged gained from this study will assist 
health care professionals to better address the stress of patients who are 
hospitalized for AMI. The results of this study may assist nurses to develop 
strategies to reduce the stress associated with sudden smoking withdrawal 
following heart attack. Reductions in stress may hopefully reduce the number of 
complications and deaths that occur from heart attacks. Furthermore, reporting of 
the results of this study may serve as an incentive for those who smoke to quit 
smoking. Finally, the results of this study may provide support for further 
research studies which test the best types of smoking cessation strategies for 
heart attack patients when they are hospitalized. 
PAYMENT FOR PARTICIPATION 
You will not receive any payment for participating in this study. 
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CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can be 
identified with you will remain confidential and will be disclosed only with your 
permission. All hard copies of your data will be stored in a locked cabinet in the 
researcher's office. Data will be kept for 5 years for possible use in future studies, 
following which, the data will be shredded. 
PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not. If you volunteer to be in this 
study, you may withdraw at any time without consequences of any kind. The 
care and treatment that you receive will not be affected if you choose not to 
participate in the study. You may also refuse to answer any questions you don't 
want to answer and still remain in the study. The investigator may withdraw you 
from this research if circumstances arise which warrant doing so. You may also 
choose to withdraw your information from the study. 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS 
The research findings will be published on the Research Ethics Board website at 
the University of Windsor (www.uwindsor.ca/reb). You may also contact Kathy 
Pfaff directly (XXX-XXX-XXXX or kpfaff@uwindsor.ca) for final results of the 
study. 
SUBSEQUENT USE OF DATA 
This data may be used in future studies. 
RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your consent at any time and discontinue participation without 
penalty. If you have questions regarding your rights as a research subject, 
contact: 
Research Ethics Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4; 
telephone: 519-253-3000, ext. 3916; e-mail: lbunn@uwindsor. 
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APPENDIX C 
Instructions for Recruitment of Subjects 
Screen patients for eligibility: 
Inclusion 
• 18 years of age and older with a confirmed diagnosis of AMI who are clinically 
stable 
• Able to read and understand English 
• Clinically stable 
Exclusion 
• Unstable patients - those requiring vasoactive medications (except nitroglycerin) 
and/or mechanical ventilation. 
• A history of diagnosis with anxiety or depressive disorders. 
• Patients involved in a smoking cessation program prior to hospital admission. 
• Patients not admitted to CCU from home i.e. not transferred from another unit or 
hospital. 
Approach the subject on day two after admission to the CCU: 
"Hi Mr./Ms. , my name is and I am 
(state your relationship to the patient - e.g. staff nurse on the 
unit/reseach assistant). I am also part of a team of researchers doing a study to find out 
about how smoking withdrawal affects the stress levels and the recovery of people who 
have experienced a heart attack. Would you mind answering a few questions to see if you 
would be eligible to participate in the study? 
1. Are you a smoker - this includes any nicotine product (cigarettes, pipe, cigars, 
chewing tobacco). If yes, were you using anything to help you quit smoking 
before you were admitted to the hospital? 
2. Are you being by your doctor treated for anxiety or depression?" 
If he/she doesn't qualify, explain this and thank him/her. 
If he/she does qualify explain that: 
"You qualify to participate in this study. The purpose of this study is to determine if there 
is a difference in the stress levels and recovery between smokers and non-smokers who 
have had a heart attack. If you choose to participate I will leave with you a survey 
package that you may complete as you feel able. The survey asks questions about: 
• The symptoms of stress that you are feeling right now 
• Your sleeping patterns right now 
• Yourself and your health 
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It will take you about 15 to 20 minutes. We will also record some information about your 
medical history from your chart. I will give you a copy of the information that will be 
taken from your chart. Would you consider participating in this study?" 
If yes, review the consent form with the patient, including the chart data form. 
Ensure that he/she understands the risks, benefits, and that participation is 
voluntary. The patient signs two copies of the consent and keeps one for him/herself. 
The patient also keeps the letter of information. Once the patient completes the 
survey, ask him/her to seal the envelope and place it in the drop box. Record the 
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